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The aim of this study is to develop highly enantioselective phase-transfer 
desymmetrization catalyzed by chiral bisguanidiniums. A new chiral entity, bisguanidinium, 
has been developed and found as an excellent chiral phase-transfer catalyst.  
A series of chiral phase transfer catalysts pentanidiumm salts, biguanidinium salts and 
trisguanidinium salts were designed, synthesized and characterized. The synthetic procedure 
was also optimized to be more simplified and enable more modification on the catalysts’ 
structures, and gram-scale synthesis of the catalysts was also realized 
With those chiral phase-transfer catalysts in hand, we studied the desymmetrization of 
dibromoketones with various aliphatic and aromatic acetates. Excellent yields (up to 96%) 
and ee values (up to 90%) were achieved. Further transformation of the products which 
enabled multicyclic structures was explored. 
Mechanistically, base on the experimental characterization of the intermediates, we 
proposed that the desymmetrization of dibromoketones under phase transfer condition 
proceed through two different pathways. 
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Asymmetric Phase Transfer Catalysts  





1.1 Introduction to Asymmetric Phase Transfer Catalysis 
In 1966, Makosza and Brandstrom reported the alkylation of indene 1 with alkyl 
halide 2 by using triethyl benzylammonium chloride as catalyst in the presence of an 
aqueous Sodium hydroxide solution.
1
 Compared with the classical methods using strong 
hydride base, and strictly anhydrous medium. This system could also obtain satisfied 
results. Later in the same year, Makosza reported the Vinylation of phenylacetonitrile 
derivatives using the same catalyst.
2 
These reports build up the foundation of phase 
transfer catalysis. 
 
Scheme 1.1 Alkylation of indene 1 and vinylation of phenylacetonitrile 4 
In 1971, Starks introduce the concept of phase transfer catalysis.
3
 In this article, 
Starks used the cyanidation of alkyl bromide as model. (Scheme 1.2) The quaternary 
phosphonium cation R4P
+
 is highly lipophilic. In aqueous phase, R4P
+
 would undergo ion 
exchange with sodium cyanide, and reach equilibrium. Differed from Sodium cation, 
R4P
+
 is organic soluble so that it can transfer cyanide anion into organic phase. As a result, 
the concentration of cyanide anion in the organic phase is increased so that the 
displacement reaction rate is accelerated, and the transformation of compound 7 to 8 can 
proceed smoothly. 




Scheme 1.2 are comparable to those obtained under mono-phase conditions, such as 
reaction using DMF as solvent. 
 
Scheme 1.2 Starks extraction mechanism of phase-transfer catalysis. 
In 1975 Makosza proposed another possible mechanism for phase transfer catalysis 
which is named as the interfacial mechanism.
4
 According to this proposal, the reaction 
system is divided into 3 regions: the organic phase, the aqueous phase and the interfacial 
region. Differed from Starks proposal, the catalysts do not travel through the borderline of 
2 phases. Instead, the substrate reacts with the anionic species at the interface and then the 
catalysts undergo ion exchange with the substrate anion. After that, these ionic species 
will react with organic soluble substrate in organic phase to complete the cycle and 
release the original catalyst species (Scheme 1.3).  
When the salt anion is strong hydrophilic so that the intermediate QX (e.g. hydroxyl 
anion) can hardly dissolved in the organic phase, the ion exchange process is tend to take 
place at the interfacial region. The Makosza’s interfacial mechanism is applied to 









1.2 Chiral Phase-Transfer Catalysts 
1.2.1 Quaternary Ammonium Salts 
One of the first asymmetric phase-transfer catalysis was reported in 1984
5a
. Dolling 
and co-workers demonstrated the enantioselective alkylation of phenyl indanone 
derivative 11 under phase transfer conditions by using cinchonine derived quaternary 
ammonium salts as catalyst. This type of catalysts could be simply be synthesized in one 
step by refluxing the readily available cinchona alkaloids 9 with benzyl halides 10 in 
ethanol. (Scheme 1.4) 
 
Scheme 1.4 Synthesis of cinchona alkaloid derived PTC 1 
This enantioselective alkylation was proceed in 2 phase system consisted of 
non-polar solvent such as toluene and aqueous sodium hydroxide solution. With the 
optimized condition, high yield and high enantioselectivity were obtained. (Scheme 1.5)  
 
Scheme 1.5 Enantioselective alkylation of indanone catalyzed by PTC 1 
They had also conducted CPK molecular models, the single-crystal X-ray structure, 




the substrate which produced the high enantioselectivity. In their proposal, the quinoline 
ring, the C-O bond, and the N-benzyl group all lie in one plane so that the catalyst can fit 
well with the phenyl indanone via π- π interaction and hydrogen bonding. (Figure 1.1)
5b
 
As a result, the catalyst blocks one side of the intermediate so that the alkylation will take 
place on the other and give high enantioselectivity.  
 
Figure 1.1 Ion pairing between indanone anion and benzyl cinchoninium cation 
Enantio-pure cinchona alkaloids are readily available reagent. Their structures are 
composed of a quinoline, a secondary alcohol, a terminal alkene, and a sterically hindered 
tertiary amine. All these subunits can be modified so that the cinchona alkaloids are able 
to show different chemical properties in different chemical processes.  
In 2011, Denmark and co-workers described the catalyst structure-activity/selectivity 
relationship of cinchona alkaloid-based asymmetric phase transfer catalysts.
6 
By using the 
benzylation of shiff base 13 as model, an array of catalysts with different modification on 
quinuclidine nitrogen were synthesized to study the the role of steric and electronic 




 Scheme 1.6 Enantioselective benzylation of shiff base 13 
A tetrahedron model was designed to explain the 3 dimensional relationships 
between shiff base anion and catalyst cation which was account for the enantioselectivity. 
Their results revealed that the enantioselectivity was primarily dependent on the steric 
bulk of substituent on ammonium center and the electronegativity of substituent at C(9). 
(Figure 1.2) On the other hand, these factors showed not clear trend on influence the 
reaction rate. 
 
Figure 1.2 Tetrahedron model for cinchona alkaloid-based catalyst enantioselectivity 
In 1999, Maruoka and co-workers reported the synthesis and application of a series 
of highly efficient phase transfer catalysts based on C2 symmetric binaphthal structures.
7
 
In the first example they reported,
7a
 Maruoka illustrated the synthesis of a novel phase 
transfer catalyst family PTC 3. These chiral spiro ammonium catalysts consist of a highly 




The catalytic ability was evaluated in the alkylation of shiff base 13. With as low as 
1 mol% of catalyst loading, good yields were obtained in short reaction time and mild 
conditions. Enantioselectivities generally exceeded 90% with different aliphatic, allylic 
and benzylic halides. (Scheme 1.7) It was also observed that the substituent difference on 
the 3, 3’-position will lead to considerable different result both in reaction rate and 
enantioselectivity. Compare to the result given by PTC 1 (73% yield and 79%ee), the 
alkylation influenced by phenyl substituted catalyst PTC 2 produce compound 15 in 81% 
yield and 89%ee, it was even improved (95% yield and 96%ee) when PTC 3 was used 
which containing the biggest substituents amoung the 3 catalysts. In the following works,
8
 
more catalysts were synthesized. 
In the mechanistic studies, X-ray results, space-filling model of a plausible 
transition-state structure was given which agreed with the proposal that aromatic 
substituents at the 3, 3’-position of one binaphthyl subunit of the catalyst (Ar) on the 
enantiofacial discrimination exhibits significant effect on products enantioselectivity. 
 




Besides the catalysts with substituents on the 3, 3’-position, later in 2003, Maruoka’s 
group designed the catalysts of which the 4, 4’ and 6, 6’ position of binaphthal structures 
were modified.
9
 In these reports, they developed a simplified pathway to synthesize PTC 
4 and PTC 5, and satisfied yields were reached. The 4, 4’ diaryl substituents catalysts 
exhibited meaningful results in benzylation of shiff base.  
 
Figure 1.3 Chiral spiro ammonium catalysts PTC 4 and PTC 5 
PTC 3, 4, 5 were conformational rigid and proved to be highly efficient in PTC, 
however the requirement of 2 chiral binaphthal moieties also limited the scope of catalyst 
design. Accordingly, Maruoka’s group developed a new class of C2-symmetric chiral 







Scheme 1.8 Enantioselective benzylation of shiff base 13 with PTC 6 
In this report, PTC 6 were synthesized and applied in the the representative phase 
transfer alkylation of shiff base 15. (Scheme 1.8) The results (95% yield and 92% ee) 
were comparable with those done by PTC 4 and PTC 5. The impressive feature was that 
PTC 6 possessed an achiral conformational flexible biphenyl subunit. It was assumed that 
efficient enantioselectivity could be derived from the considerable difference of catalytic 
activity between the rapidly equilibrated, diastereomeric homo- and heterochiral catalysts;  
Shown in figure 1.4, homochiral PTC 6a was a more efficient phase transfer catalyst 
to catalyze the alkylation, and produce compound 15 in high enantioselectivity, while 
heterochiral PTC 6b exhibit both low reactivity and stereoselectivity. The dynamic 
structural behavior of PTC 6 in solution was analyzed by a variable-temperature 1H 
NMR study. This result clearly indicates that there is a rapid equilibrium between 
homochiral PTC 6a and heterochiral PTC 6b, which was a result of the rotation about the 





Figure 1.4 Expected conformational interconversion of PTC 6b 
The success of PTC 6 proved that flexible subunits could magnify the effect of chiral 
subunits through coordinative interaction. This concept offered a new dimension in 
catalysts design. Based on this observation, Maruoka’s group developed a new type of 
catalysts PTC 7 with structural rigid binaphthal moiety on one side and highly flexible 
straight alkyl chain on the other side. 
The catalyst PTC 7 can be synthesized from commercially available 
(S)-1,1’-binaphthyl-2,2’-dicarboxylic acid in a six-step sequence. In the proposed 
mechanism, the phase transfer catalysts will move to the interfacial layer to induce ion 
exchange process, thus, by increasing polarity of the dialkylammonium moiety, the 
replacement of rigid binaphthal moiety to flexible linear alkyl chain might increase the 
exchange rate. Alkylation of shiff base 15 was carried out to examine the efficience of 
PTC 7. The assumption was confirmed by the fact that even lower the catalyst loading to 




 Scheme 1.9 Enantioselective benzylation of shiff base 13 with PTC 7 
Besides the Maruoka’s design of C2 symmetric ammonium catalysts which were 
based on binaphthal moiety, Nishida and co-workers reported novel C2 symmetric 
ammonium catalysts containing rigid spiro structures. 
11
These catalysts were synthesized 
from commercially available tartrates. The catalytic ability was examined through 
Michael addition of shiff base 13. With the optimized condition, good yield and ee were 
obtained. (Scheme 1.10) 
 Scheme 1.10 Enantioselective Michael addition of shiff base 13 with PTC 8 
Differed from the C2 symmetric ammonium catalysts described above, in 2003, 
Takabe and co-workers developed a C3 symmetric amine derived phase transfer catalyst 
PTC 9. 
12 
It was worth to note that this catalyst could easily be made in 2 steps. When 
applied to the benzylation of shiff base 13 was applied as the model reaction. Compared 




resulted in considerably higher ee value.  
 Scheme 1.11 Enantioselective benzylation of shiff base 13 with PTC 9 
It was assumed that the enantioselectivity was attributed to the hydrogen bonding 
between a hydroxyl group on PTC 9 and nitrogen on the Schiff base. In the proposed 
transition state 18, PTC 9 and E-enolate derived from deportonation of 13 form an 
ion-pair containing a nine-membered ring. With the R group locating at pseudoequatorial 
position, Benzyl bromide would approach from the less hindered face (Re-face) to afford 
the alkylation product 15 with S configuration. (Scheme 1.11) 
Inspired by Maruoka’s work in 2002 about inducing chirality
10
, Lygo and coworkers 
designed asymmetric phase transfer catalysts based on chiral spiro biphenyl structures 
based on Induced atropisomerism. 
13 
They had synthesized 40 catalysts in total, and 
applied them to the alkylation of shiff base 13 to test the efficiency and enantioselective 
control systematically. As a result the chirality inducing system proved to be successful. 
The conformationally flexible biphenyl structure would cooperate with the chiral 
secondary amine well resulted in high enantioselectivity. After optimization, the best 
catalyst PTC 10 could catalyzed the alkylation and generate product 15 in 89% yield and 




Scheme 1.12 Enantioselective benzylation of shiff base 13 with PTC 10 
Shibasaki and co-workers developed a new type of 2-center ammonium based phase 
transfer catalysts in 2002.
14
 This catalyst was designed based on molecular mechanics 
simulation using the Monte Carlo method, and could be synthesized from commercially 
available and relatively inexpensive L- or D-tartrate. To test the catalytic ability of PTC 
11, 2 types of reaction were conducted and more than 40 different catalysts were 
involved.  
As a result, both high yield and ee was achieved and desired products were 
generated. (Scheme 1.12) In the alkylation of shiff base 13, products with R configuration 
was obtained, while in the Michael addition, the shiff base 13 reacted with acrylate 22 to 
give S configuration adducts 23. These results suggested that the bis-ammonium cation 
moiety in PTC 11b functions as a bifunctional catalyst that activates and fixes 




Scheme 1.13 Enantioselective benzylation and Michael addition of shiff base 13 with 
PTC 11 
In another study described by Park and co-workers, they designed a series of dimeric 
and trimeric ammonium phase transfer catalysts based on cinchona alkaloids structures.
15
 
These catalysts could be synthesized through simple procedure with readily available 
compounds. Benzylation of shiff base was applied as the model for investigating the 
catalytic abilities and enantioselective control of this catalysts family.  
Mechanistic investigations were also carried out on the basis of X-ray 
crystallography and molecular modeling. After carefully tuning the reaction parameters 
and delicately modifying the ammonium salts structures, PTC 12 was determined to be 
extremely efficient for enantioselective phase transfer catalytic alkylation, providing a 




Scheme 1.14 Enantioselective benzylation of shiff base 13 with PTC 12 
1.2.2 Guanidinium Salts 
In 2002, Nagasawa and co-workers first introduced guanidine derivatives as phase 
transfer catalysts. 
16
 The guanidine group is a superbase that forms stabilized complex 
salts with anionic compounds through hydrogen bonding. In proteins, it contributes to the 
stabilization of the three dimentional structures. Inspired by this fact, PTC 12 was 
synthesized. This phase transfer catalyst has a guanidine group in the center surround by 
multicyclic backbone.  
It can be observed from the X-ray study results, that the backbone formed close-type 
cavity which was responsible for the asymmectic induction through steric hinderance. 
The catalytic ability was also examined by alkylation of shiff base 13, 55% yield and 90% 
ee of (R)-15 was obtained at 0
o




Scheme 1.15 Enantioselective benzylation of shiff base 13 with PTC 13 
Similarly, in 2003, Murphy and co-workers synthesized a range of C2 symmetric 
catalysts which consisted of a guanidine core and a tetracyclic structure. 
17
 They tested the 
catalytic ability teough alkylation of shiff base 13, excellent results (97% yield, 86% ee) 
were obtained. In this report, the authors also showed that this PTC 14 was also able to 
transfer other anions besides hydroxyl anion. In the expoxidation of chalcone 24, PTC 14 
showed high enantioselective control and produced compounds 25 in 93% ee. PTC 14 
itself only was also appeared to accelerate the Michael addition. 




1.2.3 Triazolium Salts 
In 2011, Ooi and co-worker developed new cationic organic catalysts with anion 
recognition ability and applied them to asymmetric alkylation of oxindoles.
18
 These 
catalysts were synthesized from L-phenylalanine and containing a 1,2,3-triazolium cation 
center. Benzylation of oxindole was performed. (Scheme 1.17) PTC 15a with hydrogen 
at both R1 and R2 give moderate result in enantioselectivity while PTC 15b and 15c only 
could generate nearly racemic products.  
These results clearly declared that both hydrogen bonding at R1 and R2 is essential 
for the asymmetry induction. It was also showed in the 
1
H NMR spectra of PTC 15a that 
with different counterions, the chemical shift of hydrogen at R1, R2 would be very 
different. After screening the substituents on Ar1 and Ar2, PTC 15d was found to be best 
catalyst and affording the desired product 27 in 99% yield and 97%ee. 







1.2.4 Crown Ether Derivatives 
     In 1981, Cram and co-workers developed a novel type of asymmetric phase transfer 
catalysts based on crown ether structures. 
19
 In the presence of PTC 16, substrate 28 
would undergo conjugate addition with 29 to give almost enantio pure product 30 in 
moderate yield. In the proposed reaction process, deportonation would take place first on 
28 to form enolate. The catalyst would then coordinate with the potassium of the enolate 
and the chiral binaphthyl group would be responsible for the asymmetry induction. 
However, the substrate scope with high enantioselectivity is limited. In another case, 
Michael addition of 31 generate product 33 with moderate ee. (Scheme 1.18) 
 
 
Scheme 1.18 Enantioselective conjugate addition of 28 and 31 with PTC 16 
     In 1998, Tŏke and co-workers test the catalytic activity of PTC 17 in conjugate 




obtained in 82% yield and 84% ee in extremely short time (1 min) with PTC 17. 
20
 The 
author also proposed the reaction mechanism and further analyzed by molecular 
mechanics calculations. There was one interesting observation that ee was dependent on 
time. After the reaction was finished at 8 min, the ee dropped to 80% and further dropped 
to 76% after another 8min. Moreover, deracemization experiment of 33 was performed 
and got 40% ee. These facts indicated that the kinetically controlled result of the C-C 
bond formation was modified by a deracemize process. (Scheme 1.19) 
Scheme 1.19 Enantioselective conjugate addition and deracemization of 31 with PTC 17 
     In 2004, Bako and co-workers developed a novel crown ether type catalyst. 
21
 
These catalysts were synthesized from α-D-glucose- and α-D-mannose. Epoxidation of 
chalcone was applied as the model to test the catalytic ability of PTC 18. The catalysts 
containing a side chain on the nitrogen atom with a hydroxyl group at its terminal 
exhibited significantly higher enantioselectivity than those without. Among those high 
performance catalysts, PTC 18b obtained the best results (94% ee). It could be conclude 
that both the length of the arm on the nitrogen atom and the hydrophilic property of the 





Scheme 1.20 Enantioselective epoxidation of 24 with PTC 18 
1.2.5 Anionic Chiral Phase Transfer Catalysts 
In 2011, Toste and co-workers introduced several examples of asymmetric 
electrophilic fluorination using an anionic chiral phase transfer catalyst.
22
 In this report, 
chiral binaphthyl phosphate catalyst PTC 19 was synthesized and applied in the 
fluorocyclization of starting material 34, and 86% yield, more than 20:1 dr and 92% ee 
were obtained with the optimized reaction condition.  
To carry out the mechanic study, six different levels of enantiopurity PTC 19 and 
used in the reaction of substrate 34. A non linear effect was observed, which supported the 
mechanism that both tetrafluoroborate anions were replaced by PTC 19 and form chiral 
ion pair 36.(Scheme 1.21) This chiral ion pair was proposed to be the key intermediate 










1.3 Development of Novel Phase Transfer Catalysts 
1.3.1 Pentanidium Salts 
In 2011, Tan and co-workers designed a series of pentanidium derived compounds 
as phase transfer catalysts.
23
 Differed from most cationic phase transfer catalysts that 
consisted of sp
3
-quaternized ammonium as reactive center, pentanidium’s core structure 
contained 5 nitrogen atoms in conjugation. The pentanidium derived compounds PTC 20 
could be synthesized in 5 steps from commercially available (S, 
S)-diphenyl-diaminoethane, and other commonly available and inexpensive reagents. 
With this compound in hand, they empolyed it as phase transfer catalyst in the conjugate 
addition.  
In the first report, Michael addition took place between shiff base 13 and acylate 22 
in the presence of PTC 20, and generated product 23 with excellent yield and ee. In 
addition to Schiff base 13, benzophenone imines of phosphoglycine ester 37 could also be 
utilized as donors in a related Michael addition reaction. (Scheme 1.22) 




     Pentanidium salts can be synthesized in five steps from commercially available 
chiral diamine 44. First, chiral diamine 44 was treated with triphosgene in the presence of 
triethyl amine to form urea 45. Without further purification, 45 directly underwent 
methylation with methyl iodide and sodium hydride. 46 could be simply be purified by 
flash column chromatography, and the overall yield of the above 2 steps is 80%. 
Imidazoline salt 47 was made from 46 by heated 46 with oxalyl chlroride in toluene 
overnight. It should be noted that if the substituents on nitrogen were not methyl group, 
step 3 would not succeed unless 46 was transferred into corresponding thiourea by 
lawesson’s reagent. To obtain guanidine 48, 47 was treated with ammonia in sealed tube 
without purification. PTC 20 was formed by directly coupled 47 with 48, and could be 
purified by recrystalization. (Scheme 1.23) 
     The whole procedure of synthesis of PTC 20 involved only 1 time of column 
chromatography in step 2 and 1 time of recrystalization in step 5. Moreover, the step 1 
can be modified according to Yamada’s report in 1991 to replace the toxic and expensive 
reagent triphosgene to urea.
24 
By using this method, the whole procedure could be less 






     Scheme 1.23 The synthesis of PTC 20 
In 2012, one new type of pentanidium PTC 21a containing bulky benzylic side 
chain was reported, and it was applied to the α-hydroxidation of oxindoles by molecular 
oxygen in basic condition.
25
 It was interesting to note that the author could synthesize 
hydroxide oxindole 42 and hydroperoxide oxindole 43 selectively by tuning the amount 
of oxygen. (Scheme 1.24) Further control experiment revealed that after enolization, 
direct oxidation formed hydroperoxide product 43 first, and then it reacted with another 
molecule of enolate 41 through a kinetic resolution process to form hydroxide product 42. 
Both steps enriched the enantio purity. 




Recently, further development on pentanidium was made. Bromine atoms was 
introduced on the side chain to form halogen bonding which was proved to be responsible 
for the improvement in enantioselectivity.
26 
 
1.3.2 Bisguanidinium Salts 
     Besides the modification on the side chain, there were several attempts on other 
directions. However, most of them didn’t show satisfying results. In a recent trial, we 
managed to change the core structure from five-nitrogen system to six-nitrogen system 
which was named the bisguanidinium salts. 
 
     Scheme 1.25 The synthesis of PTC 22 
     As shown in Sheme 1.25, bisguanidinium salts PTC 22 could be synthesized in 
four steps from commercially available chiral diamine 44. First, diamine 44 was subject 
to alkylation with benzyl bromide 49, substituted diamine 50 would be obtained as the 
main product instead of mono- and tri- substituted diamine. In the following step, 50 was 
treated with thiophosgene and thiourea 51 would be formed in high yield. Compared to 
the synthetic procedure of pentanidium, the use of thiophosgene shortened the synthetic 
route and the time consumption was also decreased dramatically. This reaction should be 




chloride to form moisture sensitive compound 47. Without any purification, 52 was 
reacted with piperazine and excess of dry triethyl amine to get the bisguanidinium 
catalyst PTC 22. 
     Compared with the synthesis of pentanidium salt, the synthetic route of 
bisguanidinium salt was shorter. Differed from pentanidium catalysts, bisguanidinium 
catalysts could be modified on their linkers, which might change the configuration of the 
catalysts and further lead to significant change in catalytic ability. 
     Recently, bisguanidinium salts had shown their value in phase transfer catalyzed 
oxidation of alkenes.
27
 In this report, PTC 23b was used, and showed the ability to 
coordinate with permanganate anion and react with electron deficient terminal alkenes 53 
to form diol 54 in moderate yield and excellent ee value. Moreover, by adding acetic acid, 
instead of diol, 2-hydroxy-3-oxocarboxylic ester 55 could be generated selectively in high 
enantioselectivity. 




Further improvement was also been made by changing the bulky groups on the 
chiral centers of the diamine. According to the literature, a wide variety of chiral diamines 
58 could be obtained through Diaza-Cope rearrangement from mother diamine 56.
28
 
(Scheme 1.27) This method was the first time in the development in phase transfer 
catalysts in our group to modify the chiral centers, and thus provided an extra way to tune 
the enantioselectivity of the catalysts.  
Scheme 1.27 The synthesis of chiral diamine 58 
1.3.3 Trisguanidinium Salts 
Inspired by the synthesis of bisguanidinium, we had made several attempts on new 
catalysts design by employing different linkers. One of the examples was the C3 
symmetric catalyst temporarily named trisguanidinium. This catalyst could be synthesized 
from imidazoline salt 47 with guanidine hydrochloride. (Scheme 1.28) Its application in 
phase transfer catalysis was now under exploring. 
 




1.4 Summary and project objective 
Since phase transfer catalysis was developed, a wide range of enantioselective 
reactions has been proved to be successful in phase transfer conditions. And different 
kinds of chiral phase-transfer catalysts were synthesized from different chiral scaffolds. 
The pentanidium salts we have design were effective in conjugate addition, alkylation and 
hydroxylation. The second generation of phase transfer catalysts in our group, 
bisguanidinium was synthesized recently and also exhibited its catalytic ability in 
dihydroxylation.  
As an extension of these works, more modifications were made on the old catalysts 
structure and several of bisguanidiniums were synthesized.  
To explore the catalytic abilities of bisguanidinium derived phase transfer catalysts, 
and to understand the relationship between catalysts’ structures and their performance in 
reactions, we employed phase transfer catalysts in hand in desymmetrization reactions. 
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Bisguanidinium Catalyzed Enantioselective 








The desymmetrization of symmetric compounds consists of a modification that 
eliminates one or more elements of symmetry of the substrate. If the symmetry elements 
that preclude chirality are eliminated, enantioselectivity can be achieved. To achieve such 
an enantioselective symmetry breaking synthetic operation, two enantiotopic functional 
groups must be differentiated. Various stoicmetric chiral reagents, enzymes and 
organometalic catalysis had been proved effective in this process.
1,2
 Besides, 
organo-catalysis had also been widely employed in desymmetrization. 
2.2 Desymmetrization with Organocatalysis 
2.2.1 Epoxides 
Epoxides could be simply made from alkene precursors and because of their 
distinct structures, epoxides were one of the most popular substrates in 
desymmetrization.
3
 However, differed from the excellent achievement of organo-metalic 
catalysts, there were few reports on epoxide opening reaction mediated by 
organocatalysts. 
     In 1998, Denmark and coworkers report the enantioselective ring opening reaction 
of epoxide with silicon tetrachloride.4 This phosphoramide catalyst 61 containing a chiral 
spiro bisnaphthyl subunit and acted as a lewis base in this reaction. SiCl4 would be 
activated by 61 and then generated a highly reactive silicon cation and a chloride anion 
which was responsible for the SN2 process to produce compound 62.(Scheme2.1) Both 








Scheme 2.1 Enantioselective ring opening of epoxides 60 with Lewis acid catalyst 61 
2.2.2 Aziridines 
     Having a similar structure with epoxide, meso- aziridine was also a commonly used 
compound in desymmetrization reactions.
5
 In 2011, our group reported guanidine 
catalyzed enantioselective ring-opening reaction of aziridines.
6
 Catalyst 66 acted as a 
Brønsted base and promoted the reaction by deprotonation of thiophenol 64. Excellent ee 
and yield were obtained. By simply employing carbon disulfide and secondary amine as 
precursors, the author achieved the asymmetric ring opening of aziridines by using 
carbamodithioic acid as a nucleophile with satisfying results.(Scheme 2.2) Moreover, 
further transformations to potentially bioactive compounds were revealed.  







Meso-diol was another popular type of substrate for desymmetrization reactions.
7
 A 
wide range of different transformations could take place on meso-diols to break the 
symmetry including, O-protection, oxidation, cyclization. 
In 2011, Tan and co-workers reported a scaffolding catalyst and its application in 
enantioselective desymmetrization of meso-1,2-diols.
8
 The most interesting feature of this 
catalyst was that it could form reversible covalent bonging with the alcohol to both 
accelerate and control the selectivity in a desymmetrization reaction. In the presence of 
catalyst 70, alkyl silyl chloride and base, a wide range of cyclic and acyclic 1,2-diols 
could undergo O-protection and afford desired products in high yield and ee.(Scheme 2,3) 
Scheme 2.3 Enantioselective mono protection of diol 69 with scaffolding catalyst 70 
     Besides 1,2-diols, 1,3-diols were also widely employed as substrates in 
desymetrizations. In 2014, Yeung and co-workers reported catalytic asymmetric 
bromoetherification and desymmetrization of olefinic 1,3-diols with C2‑symmetric 
sulfides.
9
 This unique sulfide catalyst 74 is proposed to act as a Lewis acid and coordinate 
with a bromo cation generated from NBS. And then, the bromo cation would be delivered 
to the substrate olefin 73 asymmetrically to give product 75.(Scheme 2.4) A large range of 






also presented the application to the synthesis of the key intermediate of an orally active 
antifungal drug posaconazole (Noxafil). 
Scheme 2.4 Enantioselective Bromoetherification of diol 73 with sulfide catalyst 74 
2.2.4 Anhydrides 
    Meso-anhydrides were also a big class of substrates which could lead to optical 
active building blocks in natural products or bioactive compounds after 
desymmetrization.
10
 In 1999, Bolm and co-workers developed a simple and highly 
enantioselective nonenzymatic ring opening reaction of cyclic prochiral anhydrides 76.
11
 
Readily available cinchona alkaloids were utilized in this reaction as catalysts which 
allowed a wide range of structurally diverse methyl hemiesters 78 to be prepared with up  
Scheme 2.5 Enantioselective ring-opening of anhydride 76 with quinidine 77 
to 99% yield and 99% ee.(Scheme 2.5) Product with both S- and R- configuration were 








      The meso-Imides, which were derived from anhydrides, were also popular 
substrates for desymmetrization. In 1994, Speckamp and co-workers presented the 
reduction of catalytic enantioselective reduction of cyclic meso-imides. Chiral 
oxazaborolidine 80 was employed as the chiral catalyst with borane as the stoichiometric 
reductant (Scheme 2.6).
12
 Reaction of imide 79 with 0.5 equivalents of 80 and borane in 
THF provided a mixture of the cis and trans isomers of 2-hydroxypyrrolidinone 81. 
Treatment of the crude reaction product with acidic ethanol produced trans ethoxy lactam 
82 in 73% yield and 75% ee. Conversely, treatment of 81 with sodium borohydride 
followed by sulfuric acid produced lactam 83 in 76% yield and 80% ee. A wide range of 











      Cyclic meso- ketones were suitable substrates in desymmetrization.
13
 Early in 
1971, Wiechert and co-workers report the synthesis of enone 87 through 
desymmetrization.
14
 Later in 1974, Hajos and Parrish were able to isolate the intermediate 
ketol 86.
15
 This process started from meso- triones 84 which would be treated with 
catalytic amount of proline 85 in DMF, generating bicyclic ketol 86 in 100% yield and 
93%ee.(Scheme 2.7) This ketol 86 would be transferred into enone 87 in acidic condition 
without loss of enantio-purity.  
 
Scheme 2.7 Enantioselective aldol reaction of trione 84 with S- proline 85 
     Prochiral mono-ketones could be desymmetrized through 
Horner-Wadsworth-Emmons (HWE) Reaction. In 1998, Shioiri and co-workers reported 
the HWE reaction of ketone 88.
16 
Cinchona alkaloid derived phase transfer catalyst was 
employed in combination with in combination with phosphonate 150 and rubidium 
hydroxide. Under optimized condition, prochiral ketone 88 was able to desymmetrized 







Scheme 2.8 Enantioselective HWE reaction of ketone 88 with phase transfer catalyst 90 





 After initial screening, bifunctional dihydroquinine urea derivative 
93 was selected to be the catalysts. Prochiral diketones 92 was desymmetrized via an 
addition−elimination−isomerization pathway in the presense of nitroalkanes, base and 
catalyst 93 and generated alkylated compounds as desired product 94 in high yield and ee. 
It was the first time that nitroalkanes being used as alkyl source.  
 
Scheme 2.9 Enantioselective alkylation of diketone 92 with urea catalyst 93 
2.2.7 Azetidines 
      In 2015, Sun and coworkers reported the first catalytic asymmetric 
desymmetrization of azetidines.
18
 Due to the low reactivity of azetidines 95, this reaction 
should proceed at 80℃ with highly acidic catalyst. Under optimized condition, 






2-mercaptobenzothiazole and produced desired chiral amide in 94% yield and 94.5%ee. 
DFT calculation revealed that the phosphoric acid catalyst was able to activate both 
substrate and the H-bonding between catalyst and nitrogen atom on azetidines existed in 
the key intermediate. Transformations from the products to other chiral building blocks 
were also realized.  
 
Scheme 2.10 Enantioselective ring opening of azetidine 95 by phosphoric acid catalyst 97 
2.2.8 Atropisomeric Compounds 
Atropisomeric compounds were involved in desymmetrization recently. In 2014, 
Bencivenni and co-workers reported the remote control of the axial chirality of 
atropisomeric succinimides via an aminocatalytic vinylogous Michael 
addition/desymmetrization sequence of N-(2-t-butylphenyl) maleimides 100.
19
 Cinchona 
alkaloid derived primary amine catalyst 101 was employed, and responsible for the 
enamine intermediate formation. Chiral cocatalyst N-Boc-L-phenylglycine 102 
participated in the reaction by fixing the maleimide via hydrogen bonding. Under 
optimized condition, product 103 and 104 were obtained in 7:3 ration and each with 






Scheme 2.11 Enantioselective Michael addition of maleimide 100 with 101 and 102 
2.2.9 Application in total synthesis 
Symmetry implied in the structure of a large number of natural products. Synthesis 
strategy involve desymmetrization can afford the desired product easily from widely 
available symmetry molecular. This strategy (Scheme 2.12) can simplify and improve the 
efficiency of synthesis. In the past few decades, it has been developed rapidly and applied 
in a wide range of natural product total synthesis.
20 
 
Scheme 2.12 Desymmetrization strategy in total synthesis 
Cocaine was isolated from a variety of plant sources, and has a long and important 








 First meso-dialdehyde 141 was synthesized from aldehyde 140 through 
8 steps. Then using the method reported by List in 2003,
 22
 the desymmetrization of 
meso-dialdehyde 141 was achieved by intamolecular aldol reaction catalyzed with 
L-proline. Product 142 was obtained as an ax/eq mixture in 1:1 ratio. The author 
synthesized natural product (+)-cocaine 143 in 5 steps form 142 ax/eq mixture. (Scheme 
2.13) 
Scheme 2.13 The total synthesis of (+)-cocaine 
Resolvins are a new family of lipid mediators derived from omega-3 
polyunsaturated fatty acids, namely, eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), which are generated during the resolution phase of acute inflammation. In 
2009, Inoue and co-workers reported the total synthesis of resolvin E2 147.
23
 By 
employing the quinine derivative 145 and its pseudo-enantiomer 145’ as catalysts, 
meso-anhydride 144 could undergo desymmetrization and obtain (+)-146 and (+)-146 
selectively. It was interesting to note that (+)-146 and (+)-146 were able to be assembled 






Scheme 2.14 The total synthesis of resolving E2 
Acid 150 was introduced in 1964 and was used as key starting material in the 
syntheses of monoterpene indole alkaloids. In 2014, Zhu and co-workers developed a new 
strategy for the synthesis of acid 150 via bicyclic bislactone surrogate 148.
24
 In the 
presence of the chiral imidodiphosphoric acid 149, desymmtrization of 148 with an 
alcohol took place smoothly to afford enantiomerically enriched 
4-substituted-4-formylpimelate monoacids 150 in good to excellent yields and good 
enantioselectivities. The utility of 150 as chiral building block in natural products 
synthesis was illustrated by the development of a concise total synthesis of (-)-razinilam 






Scheme 2.15 The total synthesis of (-)-rhazinilam and (-)-leucomidine B 
2.2.10 Summary 
    Among the different approaches for the enantioselective synthesis of chiral 
compounds, desymmetrization has played an important role in the recent years. It is able 
to generate multi chiral centers in one step and facilitate the synthesis of complicated 
optical active compounds, which are potentially precursors of bioactive products. With 
the fast development in organocatalysis, a wide range of desymmetrization processes 
promoted by organocatalysts have been discovered. However, there were few reports on 
desymmetrization using efficient phase transfer catalysts with high enantioselectivity. It 








2.3 Phase Transfer Catalyzed Desymmetrization of Dibromoketones 
2.3.1 Initial Studies 
Initially, we were expected to realize Favorskii rearrangement in phase transfer 
condition. However, when we screen the reaction conditions use mono brominated ketone 
103 as substrate, CsOAc as the base, instead of desired product 104, compound 106a was 
observed in low yield. Control experiments revealed that there was small amount of 
dibrominated compound 105 existed in the starting material, which were responsible for 
the generating of compound 106a.(Scheme 2.16)  
Scheme 2.16 Initial attempts on Favorskii rearrangement 





H-NMR and X-ray studies showed that, the configuration of 105 
was cis.(Scheme 2.17) With the substrate in hand, we started to explore the suitable 
reaction condition.  
 







2.3.2 Optimization Studies 
Firstly, we screened the solvent effect with the commercially available cinchona 
alkaloid derived phase transfer catalyst PTC 23. This reaction did not work well in 
hexane and ether type solvents, may be due to the poor solubility of the catalyst.(table 2.1, 
entry1, 4, 5) Chlorinated solvents performed quite well, and so did aromatic solvents. 
(table 2.1, entry6-13) Mesitylene not only resulted in satisfied conv. but highest 
enantiomeric excess as well. (table 2.1, entry12) 









1 Hexane 24h <10 - 
2 Ethyl acetate 24h 80 1 
3 THF 12h 100 4 
4 Diethyl ether 24h <10 - 
5 TBME 24h <10 - 
6 DCM 6h 100 13 
7 Chloroform 6h 100 8 






9 p-xylene 12h 100 11 
10 o-xylene 12h 100 13 
11 cumene 24h 100 19 
12 mesitylene 12h 100 21 
13 chlorobenzene 24h 100 7 
a 
Reactions were performed by using 105 (0.02 mmol), and CsOAc (0.1 mmol) in 2 mL 
solvent for indicated time. 
b
 Conversion was determined by TLC. 
c
 Determined by HPLC 
analysis using Chiralcel AD-H column. 
After found out the best solvent, we began to test the various phase transfer catalysts 
in hand. PTC 24 was derived from amino alcohol, which had been proved to be effective 
structures in chiral catalyst synthesis
6
. However, not only ee, but the reaction rate was not 
comparable with cinchona alkaloid derived phase transfer catalysts. (table 2.2, entry 1) 
PTC 25 was the salt form of di-tert-butyl bicyclic guanidine, which was a very successful 
base catalysts developed by our group. Its result was not better than PTC 24’s. (table 2.2, 
entry 2) We then tried the tetra methyl pentanidium PTC 20, reaction rate was much 
improved, enantioselectivity could hardly be observed. (table 2.2, entry 3) A series of 
pentaniudiums with benzylic side chains were examined, the improvement in 
enantiomeric control was not obvious. (table 2.2, entry 5-7) At last, we used the 
bisguanidinium catalyst PTC 22, fortunately, substantial increase in ee was observed. The 
modification at Ar2 further improved the enantioselectivity.(table 2.2 entry 12-14) As 







Figure 2.1 Various phase transfer catalysts 









1 PTC24 24h 60 0 
2 PTC25 24h 80 0 
3 PTC20 12h 100 3 
4 PTC21a 24h 80 6 
5 PTC21b 24h 80 12 
6 PTC21c 24h 60 10 
7 PTC21d 24h 100 12 






9 PTC22b 12h 100 19 
10 PTC22f 12h 100(92) 30 
11 PTC22g 12h 100(95) 35 
12 PTC22h 12h 100(96) 55 
13 PTC22i 12h 100(90) 50 
14
e
 PTC22h 48h 100(95) 58 
15
f
 PTC22h 48h 100(79) 65 
16
g
 PTC22h 48h <10 - 
a 
Reactions were performed by using 105 (0.02 mmol), and CsOAc (0.1 mmol) in 2 mL 
mesitylene for indicated time. 
b
 Conversion was determined by TLC. 
c
 Isolated yield in the 
brackets, 
d
 Determined by HPLC analysis using Chiralcel AD-H column. 
e









Reaction was performed at -30℃. 
By changing the side chain from 3, 5-ditertbutyl benzyl to 3, 4, 5-trimethoxyl benzyl, 
the ee increased from 29% to 50%. (table 2.2, entry 9, 13) It was interesting that different 
from the previous report about pentanidium and bisguanidinium catalysts, the result 
described above showed that instead of steric effect, this reaction seems more sensitive to 
electronic effect of the catalyst. We also tried to lower the temperature. The reaction gave 
best result at -20
o
C. (table 2.2, entry 14- 16) Although the conversion did not change at 
-20
o
C, the isolated yield dropped considerably. It was also easier to observe a side product 
existed during the reaction was proceeding. We would discuss about this phenomenon in 
the following chapter. Further lower the reaction temperature to -30
o
C resulted in poor 















1 PTC21b 24h 60 12 
2 PTC21d 24h 70 8 
3 PTC22a 12h 100 10 
4 PTC22b 12h 100 22 
5 PTC22c 12h 100 18 
6 PTC22d 24h 100 17 
7 PTC22e 12h 100 3 
8 PTC22f 12h 100 35 
9 PTC22g 12h 100 45 
10 PTC22h 12h 100(97) 60 
11 PTC22i 12h 100(88) 50 
12 PTC22j 12h 100(95) 58 
13
e
 PTC22h 48h 100(92) 70 
a 
Reactions were performed by using 105 (0.02 mmol), and CsOBz (0.1 mmol) in 2 mL 
mesitylene for indicated time. 
b
 Conversion was determined by TLC. 
c
 Isolated yield in the 
brackets, 
d
 Determined by HPLC analysis using Chiralcel AD-H column.
 e









We suspected that the acetate anion was too small to fit in the cavity of the catalysts, 
so we chose the Cesium benzoate as an alternative. Pentanidium catalysts still not gave 
good results. not only in enantioselectivity, but also in reaction rate. (table 2.3, entry 1, 2) 
There was also the same phenomenon that catalysts with electron rich side chains resulted 
in higher ee value than that with bulky side chains. (table 2.3, entry 3-12) It was also 
notable that even with a bulky group at the chiral center, PTC 22e give bad results, (table 
2.3, entry 7) which suggested that in this reaction, the side chain played a more important 
role in inducing the chirality. PTC 22h provided the highest ee valuev among all catalysts. 
Further lowering the reaction temperature to -20
o
C lead to a increase in enantiomeric 
excess to 70%. (table 2.3, entry 13). 
PTC 22j, with a also strong electron donating but much bulkier side chain, 
presented no better results. Considering the previous studies in our group, we tried to 
increase the steric effect first when the existing catalysts were not powerful enough, and 
from the X-ray image, PTC 20 and PTC 22 were all crowded already. The results 
presented above gave a interesting hint that in some cases, we might consider about 
















1 LiOBz(s) 5 0 - 
2 NaOBz(s) 5 0 - 
3 KOBz(s) 5 0 - 
4 Ba(OBz)2(s) 5 0 - 
5 RbOBz(s) 5 100 55 
6 CsOBz(s) 10 100 61 
7 CsOBz(s) 2 100 62 
8 CsOBz(s) 1 <10 - 
9 CsOBz(conc.) 5 0 - 
10 CsOBz(1M) 5 0 - 
a 
Reactions were performed by using 105 (0.02 mmol), and PTC 22h (0.5 mol%) in 2 mL 
mesitylene for indicated time. 
b
 Conversion was determined by TLC. 
c
 Determined by HPLC 




With the best catalyst in hand, we started to screen the cation effect of the salt. It 
seemed that the radius of the cation was essential for the smooth reaction. Only larger 






than 2 equiv. to avoid no reaction, while large excess of salt would not affect the result. 
(table 2.4, entry 6-8) No reaction when salt was added as solution. (table 2.4, entry 9, 10) 
The results implied that the reactivity of the salts might be related to basicity, and 
thus provided a clue to avoid destructive effect when we were screen the additives. 
     Based on the experience of colleagues, we began to test the effect of additives. It 
should be noted that when we were screening the base in Favorskii rearrangement 
reaction, we found that strong base like NaOH or PhONa would destroy the substrate 
automatically even in the absence of phase transfer catalysts. Thus, the additives chosen 
were neutral or acidic. Mild acid phenol caused slight decrease in ee, while stronger acid 
strongly suppressed the reaction. (table 2.5, entry 1, 2) Fortunately, we found that 
LiH2PO4 could improve the ee to 75%. (table 2.5, entry 4) We assumed that the Li salts 
acted as a Lewis acid to stabilize the ionic intermediate. 
Based on this assumption, we tested a series of inorganic Lewis acids. Li salts were 
still the best choice. Then we tested the effect of anion. LiOAc was found to be the best 
additive which caused the largest increase in enantioselectivity. (table 2.5, entry 9) 
Lowering the temperature to -20
o
C, and decrease the CsOBz to 2 equivalent resulted in 
















1 PhOH 12h 100 50 
2 AcOH 12h <10 - 
3 NaHCO3 12h 100 62 
4 LiH2PO4 12h 100 75 
5 NaH2PO4 12h 100 57 
6 KH2PO4 12h 100 65 
7 LiCl 12h 100 60 
8 LiBr 12h 100 47 
9 LiOAc 12h 100 80 
10 ZnOAc 12h 100 60 
11 CuOAc 12h 100 65 
12
d
 LiOAc 48h 89f 89 
13
d,e
 LiOAc 48h 82f 90 
a 
Reactions were performed by using 105 (0.02 mmol), and CsOBz (0.1 mmol) in 2 mL 
mesitylene for indicated time. 
b
 Conversion was determined by TLC. 
c
 Determined by HPLC 
analysis using Chiralcel AD-H column.
 d




 CsOBz reduced 
to 0.04 mmol. 
f















1 CsOAc 5 5 0 100 55 
2 CsOAc 5 5 5 100 50 
3 CsOBz 1 5 1 60 70 
4 CsOBz 1 5 5 70 78 
5 CsOBz 1 5 25 70 77 
6 CsOBz 5 5 1 100 71 
7 CsOBz 5 5 5 100 70 
8 CsOBz 5 5 25 100 79 
9 CsOBz 25 5 5 100 65 
10 CsOBz 2 10 5 100 81 
11 CsOBz 2 2 5 100 80 
12 CsOBz 2 1 5 100 80 
13 CsOBz 2 0.5 5 100 75 
14
d
 CsOBz 2 1 5 100 74 
15
e
 CsOBz 2 1 5 100 81 
a 








Conversion was determined by TLC. 
c
 Determined by HPLC analysis using Chiralcel AD-H 
column.
 d 
Reaction was performed in 1 mL mesitylene.
 e 
Reaction was performed in 4 mL 
mesitylene. 
       
Further optimization was focus on the ratio of each components of the reaction. It 
was interesting to see that LiOAc only enhanced the enantioselectivity of reaction with 
CsOBz. When CsOAc was the reactive salt, LiOAc showed no improvement in both ee 
and yield. (table 2.6, entry 1, 2) In the contrast, LiOAc not only helped to provide better 
result with CsOBz on enantioselectivity, but also improved the reaction rate. (table 2.6, 
entry 3) And the positive effect appeared only when LiOAc was more than CsOBz. (table 
2.6, entry 3-9) This observation implied that the dominant cation might coordinate with 
the intermediate for stabilization and the size difference between Li and Cs cation lead to 
the difference in enantioselectivity. PTC 22h was efficient, its loading could be lower to 1 
mol% without any loss in enantioselectivity. (table 2.6, entry 10-13) This reaction 
performed better at low concentration. (table 2.6, entry 14-15) 
2.3.3 Desymmetrization with Different Salts of Carboxylates 
After obtained the best condition, we began to screen the salt, in order to gain more 
information about the reaction feature and obtain useful product which had the potential 
for interesting further transformations. Substituted Cesium benzoic acetates basically 
gave good to excellent yield and ee. Among the substituents of benzoic acetate, 
ortho-substituents gave negative effect, large ortho-substituents resulted in both lower 






show clear affect on the result, while strong electron withdrawing group on the benzene 
ring would suppress the reaction. (table 2.7, entry 11, 15) Compare to the good results of 
aromatic acetates, other acid derivatives showed worse enantio control. (Table 2.7, entry 
17-23)  











48h 106b 92 90 
2 
129c 
48h 106c 95 85 
3 
129d 
48h 106d 82 90 
4 
129e 
48h 106e 91 85 
5 
129f 
48h 106f 80 86 
6 
129g 
48h 106g 85 76 
7 
129h 
48h 106h 62 39 
8 
129i 
48h 106i 90 88 
9 
129j 
48h 106j 77 88 
10 
129k 
48h 106k - - 









48h 106m 84 76 
14 
129n 
48h 106n 56 69 
15 
129o 
48h 106o - - 
16 
129p 
48h 106p - - 
17 CsOAc 129a 48h 106a 96 60 
18 HCOOCs 129q 48h 106q 85 20 
19 129r 48h 106r - - 
20 129s 48h 106s 80 24 
21 
129t 
48h 106t 80 68 
22 129u 48h 106u 89 70 
23 129v 48h 106v 90 15 
a 
Reactions were performed by using 105 (0.02 mmol), CsOBz (0.04 mmol), LiOAc (0.1 
mmol) and PTC22h (1mol%) in 2 mL mesitylene for indicated time. 
b
 Isolated yield 
c
 
Determined by HPLC analysis using Chiralcel column. 
Among these salts, conjugated acetates gave much better results. Considering of the 
electronic effect of the side chain of the catalysts, we suspected that there might be 







2.3.4 Desymmetrization with Different Dibromoketones 
At last, we tried to synthesize different dibromo ketone substrates. Prochiral dibromo 
cyclohexanone could be synthesized through the pathway shown. (Scheme 2.18)
25 
To 
synthesize the cyclic meso structures, we started from the simple ketone 108. In path A, 
the first step was to replace the ketone with alkene through Wittig reaction. Oxone 
involved epoxidation followed by Lewis acid catalyzed rearrangement resulted in the 
desired aldehyde 109 with a neighboring tertiary carbon. In path B, we used Wittig 
reaction to install a methyl enol ether directly, and then hydrolyzed by strong acid to 
obtain the target aldehyde 109. With the aldehyde 109 in hand, we employed a 
Michael-aldol cascade reaction to construct the ring structure. Reduction and 
dibromination would lead to target product, which was also the substrate 112 for 
desymmetrization.  







It should be noted that according to the previous report, cis-isomer is less stable than 
trans-isomer. In the case of substrate 105, cis-isomer was dominant and could be isolated 
from trans-isomer. However, under the same condition, trans-112a, and trans-112c would 
be the main products. When treated with the standard phase transfer condition, trans 
substrate would resulted in racemic product. Fortunately, we successfully isolated the 
desired product 112b, and when subjected to the phase transfer desymmetrization, 112b 
could resulted in satisfied results. (Scheme 2.19) The reactivities of dibromoketone with 
the similar structure were under investigation. 
 
Scheme 2.19 Desymmetrization of dibromoketone 112b 
Dibromo ketone 115 would be another suitable substrate for this reaction, and its 
synthetic route was reported by Mihovilovic and co-workers. (Scheme 2.20)
26
 The 
desymmetrization of 115 was in progress. 
Scheme 2.20 Synthesis of substrate 115 
2.3.5 Further Transformation of Products 
We also tried to explore the potential transformation that could take place on the 
product. According to the literature, photo promoted cycloaddition,
27






catalyzed intramolecular coupling 
28
 and lewis acid catalyzed diels-alder cycloaddition
29
 
were possible. (Scheme 2.21) We would try to synthesis them and explore their further 












     As a conclusion, bisguanidinium successfully employed as a phase transfer catalyst 
in the asymmetric desymmetrization of dibromoketones. Good yield and ee could be 
achieved for the desymmetrization of cyclic dibromoketones with Cesium acetates. 
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3.1 Previous study in desymmetrization of dibromoketones 
In 1967, Bordwell and co-workers studied the transformation of 
cis-dibromo-ketone 120 with sodium acetate in acetic acid.
1
 (Scheme 3.1) Keto-enol 
acetates 124 and 124’ were the 2 main products.  
 
Scheme 3.1 Previous study of transformation from 120 to 124 
Under mild condition, it was able to isolate cis-2- acetoxy - 6 - bromo - 4,4- 
dimethylcyclohexanone 121. Furthermore, 120 and 121 reacted with sodium acetate 
under comparable condition to give the same ratio of 124 and 124’. The author assumed 
that 121 was the key intermediate in this reaction.  
Based on the experiment data, the author proposed 5 reaction pathways. (Scheme 
3.3) In path A, 121 would first tautomerize to its enol form, and followed by SN2’ process 
to obtain the corresponding enol. Acetyl transfer reaction takes place to produce 
compound 123, and dehydration leads to product 124.  
In path B and C, acetate ion attacks the carbonyl group with consequent epoxide 
formation. In path B, a second acetate ion opens the epoxide by attack on one of the 
acetoxy groups. A proton shift and loss of acetate ion gives the diketone, which can be 
reacetylated by the acetic anhydride released in the previous step to form 124 and 124’. In 
mechanism C, acetate ion removes a proton from the epoxide; 1,4-elimination of acetate 




In path D, acetate ion removes a proton in the initial step. Intramolecular 
rearrangement of the acetyl group then gives an intermediate that can form 124 by a 
1,4-elimination of bromide ion. Path E differs from D only in the order of the steps 
following proton abstraction. Here the bromide ion is lost first to form a dipolar ion. 
Intramolecular rearrangement of the acetyl group then gives 124.  
 
Scheme 3.2 Proposed mechanism of transformation from 120 to 124 
    To verify these mechanisms, the author investigated the reaction of 121 with sodium 
propionate in propionic acid solvent. 1H-NMR results revealed that 124 was the only 
product and another possible product 124’ was not observed. (Figure 3.1)The experiment 
clearly showed that after 121 being formed, external acetate would not incorporate into 




was second acetate participated in the process. The discussion of distinguishing path D 
and E was out of their reach. 
 
Figure 3.1 Reaction with different acetates 
In 1977, Ohashi and co-workers reported a rearrangement of dibromoketones.
2
 They 
tested the reaction of dibromoketone with various bases. In one of the example, they 
employed 2,6-dibromo-4-methylcyclohexanone 125 and morpholine as substrates. As a 
result, Favorskii rearrangement product 127 was dominant, and 2 different enamino 
ketones 126 and 128 were obtained as minor products. (Scheme 3.3) 
Scheme 3.3 Previous study of transformation from 125 to 128 
They proposed 3 different pathways to explain the formation of the 3 products. Path 
A started with deprotonation and resulted in the Favorskii product through a cycloprotane 
intermediate. Path B started with SN2 substitution while path C started with nucleophilic 









3.2 Mechanistic Studies of Phase Transfer Catalysis Conditions 
3.2.1 Intermediate Isolation 
Inspired by the reports above, we began to study the mechanism of our reaction 
through the same pattern. Considering that Bordwell’s reaction was similar with ours, we 
use his proposal(Scheme 3.2) as guide. First we tried to isolate the intermediate, 
mono-substituted product 130. However, in the initial trial, we used Cesium 
2-methylbenzoate 129b as reactant, the isolation of 130b was not successful even at lower 
temperature. The corresponding intermediate 130b was not observed. According to the 
substrate screening, (table 2.7) there was a clear trend that steric hindered Cesium salts 
not only slowed the reaction rate, but also lowered the enantioselectivity. Based on this 
observation, we selected steric hindered salts 129h and 129p as the probe to study this 
reaction. Fortunately, 130h and 130p, 131p was isolated in moderate yield. It was worthy 
to note that 131h was obtained as pure cis configuration which suggested that 131h was 
generated through 2 times of SN2 substitution. (Scheme 3.5)  




Since the epoxide intermediate 133 was not observed, and to simplify the 
mechanistic study, we assumed that the mechanism proposed by Ohashi (Scheme 3.4 path 
C) was not reasonable in this phase transfer process. 
3.2.2 Effect of external anion 
 Scheme 3.6 External anion effect on 105 
With the intermediate 130h in hand, we first tested the affect of external anion. 
When intermediate 130h was treated with the Cesium acetate under standard 
desymmetrization reaction condition, 106h was obtained as the only product and 106a 
was not detected. (Scheme 3.6) This fact implies that the Cesium salt would possibly only 
work as a base. 
Based on Bordwell’s studies, we proposed the mechanism for this phase transfer 
desymmetrization. (Scheme 3.7) In the path A-C of the following mechanism proposals, 
after the step of intermediate 130h formation, the additional acetate would act as 
nucleophile and result in 106a. Contradicted with the experimental results, path A-C are 





Scheme 3.7 Proposed mechanism of 105 
3.2.3 Effect of chiral catalysts 
    We then studied the chirality induction of the catalyst. 130h synthesized by achiral 
catalyst was racemic, and further transferred it to 106h by chiral catalyst also resulted in 
racemic compounds. (Scheme 3.8) 
On the other hand, under chiral phase transfer catalysis condition, 130h was obtained 
in 33%ee, and further transformation under achiral catalyst resulted in racemic 
compounds. (Scheme 3.8)  
Based on this experimental fact, we assumed that the chirality is induced in both the 




second step. In other words, the chirality of 106 derived from both steps. It was also 
suggested that chiral catalysts interact with the substrate in the whole process. Review 
mechanism proposal (Scheme 3.7), anionic intermediate in path D would coordinate with 
bisguanidinium cation better than zwitterionic intermediate in path E, so path D is more 
likely to be the real mechanism. 
Scheme 3.8 Control experiments of 130 
3.2.4 Effect of Substrates’ Configurations 
     In 1953, Corey reported the stereochemistry of dibromoketones. Based on the result 
of one previous study, trans dibromoketone was more stable than cis dibromoketone.
3
 It 
suggested that trans isomer could be transferred from cis isomer through isomerization. 
By employed the same condition, we repeat this reaction using cis-105 as substrate, 
which resulted in a 1.55/2 ratio of cis/trans isomers. We subjected this mixture to the 
phase transfer condition with PTC 22h, could obtained the product 106a in 92% yield 
and 22% ee. Associated with the result that pure cis-105 give 55% ee under the same 





     
 
Scheme 3.9 Isomerization of cis-105 and further transformation 
     In another example, we isolated the trans-112a, and employed it in the phase 
transfer desymmetrization. Poor enantioselectivity was observed. (Scheme 3.10) As a 
conclusion, only cis isomer led to high enantioselectivity.  
      
 
Scheme 3.10 Transformation of trans-112a 
    When using cis substrates 105 under chiral phase transfer condition, 130 would be 
dominant while under achiral phase transfer condition, there would be comparable 
amount of 130 and 130x generated. In the following deprotonation step, 130 would form 
the same anionic intermediate as 130y generated form trans-105. It could be safely 
assumed that if 130y could be generated selectively, in the presence of chiral phase 
transfer catalyst, 106 would possibly be formed with high enantiomeric excess. However, 




ratio. The catalyst possibly could not differentiate from the generation of either 130y and 
130z or 130y and 130y’. 






3.3 Conclusion and future plan 
As discussed above, we can conclude that: 
(1) Before 106 is formed, 130 is the key intermediate 
(2) 130 is formed through enantioselective SN1 substitution controlled by chiral 
phase transfer catalyst. 
(3) The process of 130 to 106 also requires chiral phase transfer catalyst for 
enantioselectivity. 
(4) Only cis-dibromo ketones are the suitable substrates through this transformation 
which also can be treated as desymmetrization process. trans-dibromo ketones 
are not. 
Thus, we proposed the mechanism below. (Scheme 3.12) Firstly, bisguanidinium 
catalyst undergoes ion exchange reaction to form bisguanidinium acetate(GOAc), thus  
transfers acetate anion into organic layer and reacts with substrate cis-105 through 
enantioselective SN1 process to form intermediate 130. Then, GOAc acts as a base to 
deprotonate 130 to form enolate 135. 135 is coordinated with bisguanidinium cation and 
proceeds acyl transfer reaction to form 136. Finally, debromination takes place on 136 
and release product 106 and catalyst cation. 
It should be noted that because 130 could only be obtained now when certain salts 
are used, the possibility of mechanism not involving 130 cannot be excluded. It is also 
interesting to stop the reaction at 130, and for the complementary of the mechanistic study, 
we are now optimizing condition to isolate 130 with high yield and ee. We are also trying 




controls the enantioselectivity. 
    Because the configuration of the substrate also affects the final product, it is also our 
task to find out ways to selectively synthesize cis-dibromo ketones of all kinds. 
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4.1 General Information 
4.1.1 General procedures and methods 
Experiments involving moisture and/or air sensitive components were performed 
under a positive pressure of nitrogen in oven-dried glassware equipped with a rubber 
septum inlet. Air sensitive reagents were weighed in a glovebox. Dried solvents and 
liquid reagents were transferred by oven-dried syringes or hypodermic syringe cooled to 
ambient temperature in a desiccator. Reactions mixtures were stirred in round bottle 
flasks or 4mL sample vials with Teflon-coated magnetic stirring bars unless otherwise 
stated. Moisture in non-volatile reagents/compounds was removed in high vacuo by 
means of an oil pump and subsequent purging with nitrogen. Solvents were removed in 
vacuo under ~30 mmHg and heated with a water bath using Heidolph or IKA rotary 
evaporator with Eyela A-3S aspirator. The condenser was cooled with running water at 
0 °C. Reactions requiring temperatures −20 °C were stirred in either Thermo Neslab 
CB-60 with Cryotrol temperature controller or Eyela PSL-1400 with digital temperature 
controller cryobaths. Technical grade isopropanol was used as the bath medium. All 
experiments were monitored by analytical thin layer chromatography (TLC). TLC was 
performed on pre-coated plates, Merck 60 F254. After elution, plate was visualized under 
UV illumination at 254 nm for UV active material. Further visualization was achieved by 
staining KMnO4, ceric molybdate, or anisaldehyde solution. For those using the aqueous 
stains, the TLC plates were heated on a hot plate. Columns for flash chromatography (FC) 
contained silica gel 60 (0.040 mm - 0.063 mm, Merck). Columns were packed as slurry of 




use. The analyte was loaded neat or as a concentrated solution using the appropriate 





C NMR spectra were recorded on a Bruker ACF300 (300MHz), Bruker DPX300 
(300MHz) or Avance 500 (500 MHZ) spectrometer. Chemical shifts are reported in parts 
per million (ppm). The residual solvent peak was used as an internal reference. Low 
resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high resolution 
mass spectra were obtained on a Waters Q-tof Premier MS spectrometer. Infrared spectra 
were recorded on a BIO-RAD FTS 165 FTIR spectrometer. Enantiomeric excess values 
were determined by chiral HPLC analysis on Shimadzu LC-20AT and LC-2010CHT 
HPLC workstations. Optical rotations were measured in ethyl acetate using a 1 mL cell 
with a 1 dm path length on a Jasco P-1030 polarimeter with a sodium lamp of wavelength 
589 nm and reported as follows: [ ]    (c = g/100 mL, solvent). 
4.1.3 Materials 
All commercial reagents were purchased from Sigma-Aldrich, Fluka, Alfa Aesar, Merck, 
TCI, and Acros of the highest purity grade. They were used without further purification 
unless specified. All solvents used, mainly hexane (Hex) and ethyl acetate (EtOAc), were 
distilled. Anhydrous DCM was freshly distilled from CaH2. Anhydrous THF was freshly 
distilled from Na/benzophenone. MeCN and CHCl3 were distilled from CaH2. Anhydrous 
hexane was purchased from Sigma-Aldrich. All compounds synthesized were stored in a 




4.2 Syntheses and Characterizations of Chiral Phase Transfer Catalysts. 
Step 1: Dissolved chiral diamine 44 (2.12 g, 10 mmol) and triethyl amine (4.1 ml, 30 
mmol) in CH2Cl2 (25 mL), and cooled with ice bath. Triphosgene (977 mg, 3.3 mmol, 
dissolved in 5 mL CH2Cl2) was added dropwisely in 30 min length. After that, slowly 
warm to room temperature, an additional 4-5 hours of stirring was required to allow the 
reaction to complete (monitored by TLC). After diamine 81 was completely consumed, 
reaction was quenched by water (20 mL) and extracted using CH2Cl2 3 times (20 mL x 3). 
The combined organic layer was washed by brine and dried by Na2SO4. CH2Cl2 was 
removed by rotary evaporation. Product 45 was pale yellow solid, which can be used in 
the next step without any further purification.  
Modified Step 1: 
1
 Diamine 44 (2.12 g, 10 mmol), urea (0.60g, 10 mmol), and H2O (10 
drops) were heated to 200
o
C on oil bath for 2h. 45 was obtained by flash chromatography 
(silica gel, ethyl acetate), as white solid, 1.90g, 80%yield. 
Step 2: To a suspension of NaH (720 mg, 30 mmol, 3.0 equiv) in THF (15 mL) was 
added a solution of 82 (from step 1) in THF (20 mL). After 30min, the reaction mixture 




over 30min. After completion of the reaction (monitored by TLC), the mixture was 
filtered through a short pad of Celite. Solvent was removed under reduced pressure and 
46 was obtained by flash chromatography (silica gel, hexane-ethyl acetate 3:1), as a white 
solid, 2.10 g (2 steps, 85% overall yield).  
Step 3: Connect a 100 mL RBF with condenser, vacuum dry and filled with N2. Then it 
was charged with a solution of 46 (0.8 g, 3 mmol, 1 equiv) in toluene (30 mL), (COCl)2 
(2.6 mL, 30 mmol, 10 equiv) was added via syringe in one portion. The mixture was 
heated to 90
o
C and maintained overnight until 46 was completely reacted (monitored by 
LC-MS). Toluene was removed under reduced pressure and pale yellow solid 47 (0.97 g) 
was obtained for the next step without any purification. (This reaction was repeat once, 
the first batch reserved for step 4 and the second reserved for step 5. 47 is air and 
moisture sensitive. It was suggested that 47 to be made just before use, otherwise 47 
should be stored under nitrogen atmosphere or vacuum.)  
Step 4: 47 (970mg) was dissolved by dry MeCN/MeOH (volume ratio 1:1, 20 mL) in a 
seal tube, NH3 was bubbled into the solution at 0 
o
C for 0.5 h. After the introduction of 
NH3, the seal tube was sealed and the temperature was maintained at 60 
o
C. After stirring 
overnight to complete reaction, pressure was released and water was added (40 mL). The 
mixture was extracted by CH2Cl2 3 times (20 mL x 3). The combined organic layer was 
dried by Na2SO4. After removing solvent under reduced pressure, guanidine 85 was 
obtained as a brown solid, 805 mg, >99% yield.  
Step 5: To a solution of 48 (805 mg, 3.06 mmol) and triethyl amine (1.80 mL, 12.96 




MeCN (10 mL) was added in a dropwise manner. The reaction mixture was stirred 
overnight. Reaction was quenched by water (20 mL), and extracted using CH2Cl2 3 times 
(20 mL x 3). The combined organic layer was dried by Na2SO4. Solvent was removed 
under reduced pressure. The brown solid obtained was re-crystallized by CH2Cl2/ethyl 
acetate solvent system. Chiral pentanidium chloride PTC 20 was isolated as a white solid, 
760mg, 44.5% yield. 
 
(S, S)-Tetraphenyl-tetramethyl-pentanidium chloride (PTC 20): white solid, 
1
H NMR 
(500 MHz, CDCl3): δ 7.36-7.34 (m, 12H), 7.25-7.21 (m, 8H), 4.67 (s, 4H), 2.93 (s, 12H); 
13
C NMR (126 MHz, CDCl3) δ 159.4, 135.3, 129.2, 129.2, 127.6, 72.6, 32.5; LRMS (ESI) 
m/z 514.5 ([M-Cl
-
])+, HRMS (ESI) m/z 514.2970 ([M-Cl
-
])+, calc. for [C34H36N5
+
] 










equiv.) in MeCN (40 mL), was added 3,5-di-tert-butylbenzyl bromide(6.2 g, 22 mmol, 2.2 
eq, dissolved in 40 mL MeCN) dropwisely in 1h and stir at rt for 24 hr (monitored by 
TLC). After diamine 44 was completely consumed, the reaction mixture was filter 
through a short pad of Celite. Product 50 was obtained by flash chromatography (silica 
gel, hexane-ethyl acetate 20:1-10:1), as a white solid, 5.24 g, 85% yield. (Separated into 2 
batch, one for step 2, one for step 3) 
Step 2: To a solution of 50 (2.47 g, 4 mmol) in dry MeCN (15 mL) under nitrogen 
atmosphere was added BrCN (424 mg, 4 mmol, 1 eq). And the whole solution was heated 
to reflux for 6 hr and cool to rt, solvent was removed under reduced pressure and 
guanidium salt 48’ was obtained by flash chromatography (silica gel, CH2Cl2-Methanol 
100:1-30:1), as a white solid, 2.59 g, 90% yield. 
Step 3: To a solution of 50 (2.47g, 4 mmol), K2CO3 (1.21g, 8.8 mmol, 2.2 equiv.) in 
CH2Cl2/H2O (20 ml v/v=1:1), was added thiophosgene (506mg, 4.4 mmol, 1.1 equiv. 
dissolved in 10ml CH2Cl2) dropwisely in 5 min at 0
o
C and stir for 30 min. After 50 was 
completely consumes, the reaction mixture was extracted using CH2Cl2 3 times (20 mL x 
3). The combined organic layer was washed by brine and dried by Na2SO4. CH2Cl2 was 
removed by rotary evaporation. Product 45 was obtained by flash chromatography (silica 
gel, hexane-ethyl acetate 6:1), as a white solid, 2.37g, 90% yield. 
Step 4: Connect a 100 mL RBF with condenser, vacuum dry and filled with N2. Then it 
was charged with a solution of 51 (2.37 g, 3.6 mmol, 1 equiv) in toluene (30 mL), 
(COCl)2 (3.1 mL, 36 mmol, 10 equiv) was added via syringe in one portion. The mixture 
was heated to 90
o




by LC-MS). Toluene was removed under reduced pressure and pale yellow solid 52 was 
obtained for the next step without any purification. (52 should be stored under nitrogen 
atmosphere or vacuum.)  
Step 5: The above solid 52 was dissolved in dry MeCN (20 ml) under nitrogen 
atmosphere, and then guanidium salt 48’ (2.59g, 3.6 mmol, 1 equiv.) was added, followed 
by the addition of triethyl amine (1.51 ml, 10.8 mmol, 3 equiv.). Then the whole solution 
was heated to reflux for 24 h and cool to rt. Add 1M HCl (40 ml) to the reaction solution 
and the mixture was extracted by CH2Cl2 3 times (20ml x 3). The combined organic layer 
was dried by Na2SO4. Solvent was removed under reduced pressure and PTC 21 was 
obtained by flash chromatography (silica gel, CH2Cl2-Methanol 100:1-20:1), as a pale 




m chloride(PTC21b); white solid, 
1
H NMR (500 MHz, CDCl3) δ 7.39 – 7.36 (m, 1H), 
7.31 – 7.27 (m, 3H), 6.95 – 6.85 (m, 5H), 5.20 (d, J = 14.5 Hz, 1H), 4.40 (s, 1H), 4.11(d, 
J = 14.5 Hz, 1H), 3.74(s, 1H)1.11 (s, 18H); 
13
C NMR (126 MHz, CDCl3) δ 152.0, 136.3, 
131.5, 129.8, 129.5, 127.1, 123.2, 122.4, 68.1, 64.0, 49.2, 34.7, 31.2; LRMS (ESI) m/z 


















The synthesis of 52 was same with the procedure reported for PTC 21. 
Step 4: The above solid 52 (3.6 mmol) was dissolved in dry MeCN (20 ml) under 
nitrogen atmosphere, and then piperizine (92.88mg, 1.08 mmol, 0.3 equiv.) was added, 
followed by the addition of triethyl amine (1.51 ml, 10.8 mmol, 3 equiv.). Then the whole 
solution was heated to reflux for 24 h and cool to rt. Add 1M HCl (40 ml) to the reaction 
solution and the mixture was extracted by CH2Cl2 3 times (20ml x 3). The combined 
organic layer was dried by Na2SO4. Solvent was removed under reduced pressure and 
PTC 22 was obtained by flash chromatography (silica gel, CH2Cl2-Methanol 100:1-20:1), 
as a light brown solid 
 
 
PTC 22a, light brown solid, 
1
H NMR (400 MHz, CDCl3) δ 7.30 (dd, J = 5.0, 1.5 Hz, 




14.7 Hz, 4H), 4.82 (d, J = 14.7 Hz, 4H), 4.73 (d, J = 9.5 Hz, 4H), 4.48 (d, J = 9.5 Hz, 4H), 
4.32 (s, 4H), 1.14 (s, 72H); 
13
C NMR (100 MHz, CDCl3) δ 162.68, 151.30, 137.67, 
131.89, 129.58, 129.16, 126.51, 123.37, 122.26, 70.39, 54.52, 48.99, 34.69, 31.37, 31.28; 




: 668.4944;  
 
PTC 22f light brown solid, 
1
H NMR (500 MHz, CDCl3) δ 7.33 (t, J = 6.8 Hz, 12H), 7.27 
– 7.10 (m, 8H), 6.35 (d, J = 1.6 Hz, 8H), 6.24 (s, 4H), 5.00 (d, J = 15.5 Hz, 4H), 4.67 (d, J 
= 15.4 Hz, 4H), 4.57 (s, 4H), 3.64 (s, 24H), 3.26 (d, J = 54.6 Hz, 2H).
13
C NMR (126 
MHz, CDCl3) δ 161.09, 136.73, 135.60, 129.60, 127.16, 110.00, 105.89, 101.04, 71.25, 











H NMR (400 MHz, MeOD) δ 8.28 (s, 13H), 9.22 – 7.97 (m, 
122H), 9.22 – 7.67 (m, 159H), 9.22 – 7.10 (m, 233H), 7.06 – 7.01 (m, 1H), 6.99 – 6.94 
(m, 1H), 6.79 (s, 6H), 6.59 (s, 66H), 5.44 (s, 4H), 5.05 – 4.75 (m, 8H), 3.70 (s, 12H), 3.51 
(s, 24H). 
13
C NMR (101 MHz, MeOD) δ 157.18, 141.85, 138.04, 133.64, 133.38, 130.12, 




, HRMS (ESI) 724.3360, 











light brown solid, 
1
H NMR (500 MHz, MeOD) δ 7.91 – 7.35 (m, 24H), 6.91 (s, 
8H), 6.55 (d, J = 206.1 Hz, 4H), 5.18 (d, J = 78.7 Hz, 4H), 4.71 (d, J = 42.0 Hz, 8H), 3.31 
(s, 12H), 0.97 (s, 72H). 
13
C NMR (126 MHz, MeOD) δ 159.85, 144.07, 134.18, 129.51, 












Step 1: To a solution of mother diamine 56 (1.21g, 5 mmol) in DMSO (10ml), 
1-naphthaldehyde 57 (1.872g, 12 mmol, 2.4 equiv.) was added in one batch and stirred for 
24h at rt. After the reaction was complete, H2O (20ml) was added and the mixture was 
extracted by ethyl acetate 3 times (10ml x 3). The combined organic layer was dried with 
Na2SO4 and ethyl acetate was removed under reduced pressure and yellow solid 
intermediate A was obtained for the next step without any purification. 
Step 2: To a solution of intermediate A in dry THF (20ml), HCl (3ml conc.) was added. 
The mixture was reflux for 6h and cooled to rt. Then the mixture was filtered and washed 






4.3 Syntheses and Characterizations of Substrates 
Representative procedure for the synthesis of dibromoketones: 
 
To a solution of 107 (1.54g, 10 mmol) in AcOH (10ml), Br2 was added dropwise over 1h 
at rt, and stirred for an additional 2h. Then H2O (30ml) was added to quench the reaction, 
and extracted by diethyl ether (30ml). Hexane (30ml) was added to the organic layer, then 
the mixture was washed by H2O (40 ml), NaHCO3 (sat. 30 ml x 2), brine (30 ml) and 
dried by MgSO4. The solvent was removed under reduced pressure and the product 105 




2,6-dibromo-4-(tert-butyl)cyclohexanone: white solid, 66% yield; 
1
H NMR (500 MHz, 
CDCl3) δ 4.71 (dd, J = 13.3, 5.4 Hz, 2H), 2.78 – 2.63 (m, 2H), 1.98 (q, J = 12.7 Hz, 2H), 
1.79 (tt, J = 12.5, 3.0 Hz, 1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.98, 52.95, 
48.89, 40.81, 32.88, 27.54.; HRMS (EI) m/z 309.9567, calc. for [C10H16Br2O] 309.9568. 
 
2,6-dibromo-4-phenylcyclohexanone: white solid, 42% yield; 
1
H NMR (500 MHz, 




1H), 4.69 (t, J = 3.1 Hz, 1H), 3.71 (ddd, J = 12.6, 8.0, 4.1 Hz, 1H), 2.88 – 2.78 (m, 1H), 
2.57 – 2.33 (m, 3H). 
13
C NMR (126 MHz, CDCl3) δ 195.12, 141.31, 128.96, 127.41, 
126.79, 49.97, 49.09, 45.92, 41.71, 39.22. HRMS (EI) m/z 329.9258, calc. for 
[C10H16Br2O] 329.9255. 
 
Representative procedure for the synthesis of cyclicketones 
 
Step 1: To a 100 ml RBF, methyltriphenylphosphonium bromide (4.28g, 12 mmol, 1.2 
equiv.), THF (40ml) was added under N2 atmosphere. The mixture was cooled to 0
o
C, and 
potassium tert-butyloxide (1.68g, 1.5 equiv.) was added in 3 batches. The mixture was 
stirred for an additional 1h and then A (1.20g, dissolved in 10ml THF) was added 
dropwisely in 10min. The reaction was stirred at rt for 4h to allow the reaction to 
complete. H2O was added to the mixture to quench the reaction and extracted by CH2Cl2 
3 times (20ml x 3). Product B was obtained by flash chromatography (silica gel, hexane), 
as colorless liquid, 1.18g, 99% yield. 




NaHCO3 (4.20g, 50 mmol, 5 equiv.) in H2O 50ml and ethyl acetate 50ml, oxone (6.15g, 
10 mmol 1 equiv. dissolved in 50ml H2O) added dropwisely in 1h, and stirred for an 
additional 1h. The mixture was extracted by CH2Cl2 3 times (20ml x 3). Product C was 
obtained by flash chromatography (silica gel, hexane: ethyl acetate= 20:1), as colorless 
liquid, 1.14g, 85% yield. 
Step 3: To a solution of C (1.14g, 8.5 mmol) in THF (20ml), BF3*Et2O (241.4mg, 1.7 
mmol, 0.2 equiv.) was added and stirred for 6h at rt. After C was completely consumes, 
the reaction mixture was extracted using CH2Cl2 3 times (20 mL x 3). The combined 
organic layer was washed by brine and dried by Na2SO4. CH2Cl2 was removed by rotary 
evaporation. Product D was obtained by flash chromatography (silica gel, hexane-ethyl 
acetate 20:1), as a colorless liquid, 1.08g, 95% yield. 
Step 4: To a solution of but-3-en-2-one (616mg, 8.8 mmol, 1.1 equiv.), and D (1.08g, 8 
mmol) in Et2O (20ml) was added KOH (179.2mg, 3.2 mmol, 0.4 equiv.) in EtOH (20ml) 
dropwisely over 30min at 0
o
C. The mixture was allowed to warmed to rt and stirred for 
12h. After D was consumed completely, HCl(40ml, 2M) was added to quench the reaction. 
The mixture was extracted using CH2Cl2 3 times (20 mL x 3). The combined organic 
layer was washed by brine and dried by Na2SO4. CH2Cl2 was removed by rotary 
evaporation. Product E was obtained by flash chromatography (silica gel, hexane-ethyl 
acetate 10:1), as a colorless liquid, 952mg, 64% yield. 
Step 5: To a solution of E (952mg, 5.1 mmol) in THF (10ml), Pd/C (20mg) was added, 
and the system was filled with H2 gas. The reaction was stirred for 6h and filtered through 




as colorless liquid, 950mg, 98.7% yield. 
Products obtained are known compounds. 
5 
  
1-methyl-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one colorless liquid 64% yield, 
1
H NMR 
(500 MHz, CDCl3) δ 7.41 – 7.34 (m, 4H), 7.28 (d, J = 3.3 Hz, 1H), 6.96 (dd, J = 10.2, 0.8 
Hz, 1H), 6.15 (d, J = 10.2 Hz, 1H), 2.43 (ddd, J = 11.9, 6.8, 4.4 Hz, 1H), 2.36 – 2.24 (m, 
2H), 2.22 – 2.12 (m, 1H), 1.59 (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 199.50, 157.13, 
145.28, 128.64, 128.58, 126.79, 126.17, 40.61, 38.13, 34.63, 27.61. HRMS (EI) m/z 




colorless liquid 99% yield, 
1
H NMR (500 MHz, 
CDCl3) δ 7.49 – 7.35 (m, 4H), 7.30 – 7.22 (m, 1H), 2.50 (ddd, J = 11.2, 4.3, 2.7 Hz, 2H), 
2.35 (ddd, J = 15.5, 10.3, 7.1 Hz, 4H), 2.02 – 1.90 (m, 2H), 1.33 (s, 3H). 
13
C NMR (126 
MHz, CDCl3) δ 211.73, 146.00, 128.84, 126.21, 125.65, 38.39, 37.76, 37.24, 31.13. 
HRMS (EI) m/z 188.1215, calc. for [C13H16O] 188.1201. 
 
2,6-dibromo-4-methyl-4-phenylcyclohexanone brown solid 50% yield, 
1
H NMR (500 




3.25 (ddd, J = 9.1, 7.7, 3.9 Hz, 2H), 2.37 (t, J = 13.7 Hz, 2H), 1.30 (s, 3H). 
13
C NMR 
(126 MHz, CDCl3) δ 192.66, 129.79, 129.06, 127.40, 125.03, 50.48, 49.36, 43.52, 32.97. 





4.4 Phase transfer catalyzed desymmetrization 
Representative procedure for phase transfer catalyzed desymmetrization 
 
Cis-105 (31.2mg, 0.1 mmol)，PTC22h (1.52mg, 0.001 mmol, 1 mol%) and LiOAc (33mg, 
0.5 mmol, 5 equiv.) were placed in mesitylene (2ml) and stirred at 0
o
C for 20min. Then 
the CsOBz (50.8mg, 0.2 mmol, 2 equiv.) was added in one potion. The reaction mixture 
was stirred at -20 
o
C and monitored by TLC. After indicated time, upon complete 
consumption of 1, the reaction mixture was directly loaded onto a short silica gel column, 
followed by gradient elution with hexane/ethyl acetate (15:1-12:1 ratio). After removing 
the solvent, product 55b (20.9 mg) was obtained as colorless oil. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl acetate (106a) white solid 96% yield, 
1
H NMR 
(500 MHz, CDCl3) δ 6.61 (dd, J = 6.6, 2.4 Hz, 1H), 2.66 (ddd, J = 16.0, 3.5, 1.7 Hz, 1H), 
2.51 (dddd, J = 18.3, 6.3, 4.3, 1.7 Hz, 1H), 2.42 – 2.25 (m, 2H), 2,24 (s, 3H) 2.05 – 1.94 
(m, 1H), 0.94 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.65, 168.83, 145.11, 136.00, 
45.08, 39.82, 32.29, 26.98, 26.41, 20.37. HRMS (EI) m/z 210.1257, calc. for [C12H18O3] 
210.1256,     
   +22.4 (c 1.01, CHCl3); HPLC analysis: Chiralcel OD-H (Hex/IPA = 





4-(tert-butyl)-6-oxocyclohex-1-en-1-yl benzoate (106b) white solid 92% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 8.17 – 8.10 (m, 2H), 7.66 – 7.58 (m, 1H), 7.53 – 7.44 (m, 2H), 
6.75 (dd, J = 6.6, 2.4 Hz, 1H), 2.72 (ddd, J = 15.9, 3.4, 1.7 Hz, 1H), 2.58 (dddd, J = 18.4, 
6.4, 4.4, 1.8 Hz, 1H), 2.46 – 2.32 (m, 2H), 2.13 – 2.01 (m, 1H), 0.97 (s, 9H). 
13
C NMR 
(126 MHz, CDCl3) δ 192.54, 164.57, 145.30, 136.19, 133.54, 130.24, 128.88, 128.44, 
45.17, 39.94, 32.32, 27.00, 26.54., HRMS (EI) m/z 272.1412, calc. for [C17H20O3] 
272.1412,     
   +32.8 (c 1.55, CHCl3); HPLC analysis: Chiralcel AD-H (Hex/IPA = 
95/05, 0.5 mL/min, 230 nm, 23°C), 22.9 (major), 26.2 min, 90% ee. 
 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 4-methylbenzoate (106c) white solid 95% yield, 
1
H NMR (500 MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 6.74 (dd, 
J = 6.6, 2.4 Hz, 1H), 2.72 (ddd, J = 15.9, 3.4, 1.7 Hz, 1H), 2.57 (dddd, J = 18.4, 6.4, 4.4, 
1.8 Hz, 1H), 2.44 (s, 1H)2.43 – 2.32 (m, 2H), 2.12 – 2.00 (m, 2H), 0.97 (s, 9H). 
13
C NMR 
(126 MHz, CDCl3) δ 192.67, 164.65, 145.35, 144.37, 136.12, 130.30, 129.17, 126.13, 
45.19, 39.97, 32.34, 27.02, 26.56, 21.72. HRMS (EI) m/z 286.1577, calc. for [C18H22O3] 




23°C), 16.3 (major), 21,3 min, 85% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 3-methylbenzoate (106d) white solid 82% yield, 
1
H NMR (500 MHz, CDCl3) δ 7.98 – 7.90 (m, 2H), 7.39 (dt, J = 15.2, 7.6 Hz, 2H), 6.74 
(dd, J = 6.5, 2.4 Hz, 1H), 2.73 (ddd, J = 15.9, 3.4, 1.7 Hz, 1H), 2.58 (dddd, J = 18.4, 6.4, 
4.4, 1.8 Hz, 1H), 2.43 (s, 3H), 2.42 – 2.32 (m, 2H), 2.14 – 2.02 (m, 1H), 0.98 (s, 9H). 
13
C 
NMR (126 MHz, CDCl3) δ 192.67, 164.65, 145.35, 144.37, 136.12, 130.30, 129.17, 
126.13, 45.19, 39.97, 32.34, 27.02, 26.56, 21.72. HRMS (EI) m/z 286.1570, calc. for 
[C18H22O3] 286.1569, HPLC analysis: Chiralcel OD-H (Hex/IPA = 95/5, 0.5 mL/min, 230 
nm, 23°C), 19.6 (major), 23.7 min, 90% ee.  
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 2-methylbenzoate (106e) white solid 91% yield, 
1
H NMR (500 MHz, CDCl3) δ 8.08 (d, J = 8.0 Hz, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.34 – 
7.23 (m, 3H), 6.73 (d, J = 6.5 Hz, 1H), 2.73 (d, J = 16.1 Hz, 1H), 2,64 (s, 3H), 2.63 – 2.51 
(m, 1H), 2.46 – 2.31 (m, 2H), 2.15 – 2.00 (m, 1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, 
CDCl3) δ 192.70, 145.36, 141.28, 136.18, 132.67, 131.75, 131.31, 125.80, 45.22, 39.97, 
32.34, 27.02, 26.57, 21.70. HRMS (EI) m/z 286.1569, calc. for [C18H22O3] 286.1569, 




(major), 22.7 min, 85% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 4-iodobenzoate (106f) white solid 80% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 7.91 – 7.79 (m, 4H), 6.75 (d, J = 5.5 Hz, 1H), 2.77 – 2.67 (m, 
1H), 2.66 – 2.52 (m, 1H), 2.47 – 2.31 (m, 2H), 2.13 – 1.99 (m, 1H), 0.97 (d, J = 0.8 Hz, 
9H). 
13
C NMR (126 MHz, CDCl3) δ 192.40, 164.13, 145.19, 137.86, 136.32, 131.60, 
128.39, 101.57, 45.18, 39.91, 32.35, 27.02, 26.55. HRMS (EI) m/z 398.0374, calc. for 
[C17H29IO3] 398.0379, HPLC analysis: Chiralcel OD-H (Hex/IPA = 95/5, 0.5 mL/min, 
230 nm, 23°C), 20.1 (major), 24.3 min, 86% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 3-iodobenzoate (106g) white solid 85% yield,
1
H 
NMR (500 MHz, CDCl3) δ 8.46 (s, 1H), 8.08 (d, J = 7.8 Hz, 1H), 7.94 (d, J = 7.8 Hz, 1H), 
7.23 (t, J = 7.8 Hz, 1H), 6.75 (d, J = 6.2 Hz, 1H), 2.72 (d, J = 16.1 Hz, 1H), 2.65 – 2.55 
(m, 1H), 2.55 – 2.27 (m, 2H), 2.27 – 1.97 (m, 2H), 0.97 (s, 9H). 
13
C NMR (126 MHz, 
CDCl3) δ 192.36, 163.07, 145.15, 142.38, 139.01, 136.40, 130.77, 130.12, 129.41, 93.77, 
45.16, 39.88, 32.34, 27.01, 26.54. HRMS (EI) m/z 398.0384, calc. for [C17H29IO3] 
398.0379. HPLC analysis: Chiralcel AD-H (Hex/IPA = 95/5, 0.5 mL/min, 230 nm, 23°C), 





4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 2-iodobenzoate (106h) white solid 62% yield, 
1
H NMR (500 MHz, CDCl3) δ 8.06 (ddd, J = 10.6, 7.9, 1.3 Hz, 2H), 7.46 (td, J = 7.7, 1.1 
Hz, 1H), 7.28 (s, 1H), 7.21 (td, J = 7.8, 1.7 Hz, 1H), 6.79 (dd, J = 6.6, 2.4 Hz, 1H), 2.73 
(ddd, J = 16.0, 3.4, 1.7 Hz, 1H), 2.64 – 2.54 (m, 1H), 2.46 – 2.32 (m, 2H), 2.13 – 2.02 (m, 
1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.30, 164.05, 145.06, 141.58, 136.51, 
133.29, 133.10, 132.01, 127.99, 94.88, 45.13, 39.87, 32.32, 27.00, 26.53. HRMS (EI) m/z 
398.0380 calc. for [C17H29IO3] 398.0379, HPLC analysis: Chiralcel OD-H (Hex/IPA = 
95/5, 0.5 mL/min, 230 nm, 23°C), 22.9 (major), 25.9 min, 40% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 4-chlorobenzoate (106i) white solid 90% yield, 
1
H NMR (500 MHz, CDCl3) δ 8.11 – 8.02 (m, 2H), 7.51 – 7.41 (m, 2H), 6.75 (dd, J = 6.5, 
2.4 Hz, 1H), 2.72 (ddd, J = 16.0, 3.4, 1.7 Hz, 1H), 2.58 (dddd, J = 18.7, 6.5, 4.5, 1.8 Hz, 
1H), 2.45 – 2.31 (m, 2H), 2.12 – 2.00 (m, 1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) 
δ 192.40, 163.68, 145.16, 140.07, 136.31, 131.60, 128.81, 127.34, 45.15, 39.88, 32.31, 
26.99, 26.52.  HRMS (EI) m/z 306.1040, calc. for [C17H19ClO3] 306.1023, HPLC 
analysis: Chiralcel OD-H (Hex/IPA = 95/5, 0.5 mL/min, 230 nm, 23°C), 19.5 (major), 





4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 3-chlorobenzoate (106j) white solid 77% yield, 
1
H NMR (500 MHz, CDCl3) δ 8.10 (t, J = 1.7 Hz, 1H), 8.01 (d, J = 7.8 Hz, 1H), 7.65 – 
7.54 (m, 1H), 7.43 (t, J = 7.9 Hz, 1H), 6.76 (dd, J = 6.6, 2.3 Hz, 1H), 2.73 (ddd, J = 16.0, 
3.3, 1.6 Hz, 1H), 2.65 – 2.50 (m, 1H), 2.40 (ddd, J = 30.4, 15.3, 9.2 Hz, 3H), 2.07 (ddt, J 
= 14.8, 11.3, 3.9 Hz, 1H), 0.98 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.35, 145.18, 
136.39, 134.65, 133.60, 130.28, 129.79, 128.39, 45.18, 39.90, 32.36, 27.02, 26.55. HRMS 
(EI) m/z 306.1030, calc. for [C17H19ClO3] 306.1023, HPLC analysis: Chiralcel OD-H 
(Hex/IPA = 95/5, 0.5 mL/min, 230 nm, 23°C), 15,3 (major), 17.0 min, 88% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 4-methoxybenzoate (106l) white solid 94% 
yield, 
1
H NMR (500 MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 
6.74 (dd, J = 6.6, 2.4 Hz, 2H), 2.72 (ddd, J = 15.9, 3.3, 1.7 Hz, 1H), 2.57 (dddd, J = 18.4, 
6.4, 4.4, 1.8 Hz, 1H), 2.45 (s, 1H) 2.43 – 2.32 (m, 2H), 2.13 – 2.02 (m, 1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.70, 164.68, 145.37, 144.40, 136.15, 130.33, 129.19, 
126.15, 45.22, 40.00, 32.36, 27.05, 26.58, 21.75. HRMS (EI) m/z 302.1520, calc. for 
[C18H22O4] 302.1518, HPLC analysis: Chiralcel OD-H (Hex/IPA = 95/5, 0.5 mL/min, 230 






4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 2-naphthoate (106m) white solid 84% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 8.72 (s, 1H), 8.12 (dd, J = 8.6, 1.7 Hz, 1H), 7.98 (d, J = 8.1 
Hz, 1H), 7.92 (t, J = 7.8 Hz, 2H), 7.60 (dtd, J = 16.2, 6.9, 1.2 Hz, 2H), 6.80 (dd, J = 6.6, 
2.3 Hz, 1H), 2.75 (ddd, J = 15.9, 3.4, 1.7 Hz, 1H), 2.60 (dddd, J = 18.4, 6.4, 4.4, 1.7 Hz, 
1H), 2.50 – 2.37 (m, 2H), 2.16 – 2.04 (m, 1H), 0.99 (s, 9H). 
13
C NMR (126 MHz, CDCl3) 
δ 192.64, 164.74, 145.39, 136.28, 135.81, 132.43, 132.06, 129.47, 128.54, 128.27, 127.78, 
126.71, 126.08, 125.51, 45.20, 39.97, 32.35, 27.03, 26.58. HRMS (EI) m/z 322.1572, calc. 
for [C21H22O3] 322.1569, HPLC analysis: Chiralcel OD-H (Hex/IPA = 90/10, 1.0 mL/min, 
230 nm, 23°C), 12.6 (major), 14.5 min, 76% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 1-naphthoate (106n) white solid 56% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 8.96 (d, J = 8.6 Hz, 1H), 8.39 (dd, J = 7.3, 1.2 Hz, 1H), 8.08 
(d, J = 8.2 Hz, 1H), 7.91 (d, J = 8.1 Hz, 1H), 7.64 (ddd, J = 8.5, 6.8, 1.3 Hz, 1H), 7.60 – 
7.51 (m, 2H), 6.80 (dd, J = 6.6, 2.3 Hz, 1H), 2.77 (ddd, J = 15.9, 3.4, 1.7 Hz, 1H), 2.60 
(dddd, J = 18.4, 6.4, 4.5, 1.7 Hz, 1H), 2.48 – 2.37 (m, 2H), 2.16 – 2.04 (m, 1H), 0.99 (s, 
9H). 
13




131.54, 131.21, 128.49, 127.97, 126.28, 125.78, 125.54, 124.46, 45.20, 39.95, 32.31, 
26.99, 26.56., HRMS (EI) m/z 322.1569, calc. for [C21H22O3] 322.1569, HPLC analysis: 
Chiralcel OD-H (Hex/IPA = 90/10, 1.0 mL/min, 230 nm, 23°C), 15.1 (major), 18.2 min, 
70% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl formate (106 q) white solid 85% yield, 
1
H NMR 
(500 MHz, CDCl3) δ 6.72 (dd, J = 6.6, 2.3 Hz, 1H), 2.70 (ddd, J = 16.1, 3.4, 1.8 Hz, 1H), 
2.55 (dddd, J = 18.4, 6.4, 4.3, 1.7 Hz, 1H), 2.41 – 2.26 (m, 2H), 2.08 – 1.95 (m, 1H), 0.95 
(s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.13, 158.27, 144.19, 136.77, 45.06, 39.74, 
32.30, 26.96, 26.47. HRMS (EI) m/z 196.1091, calc. for [C11H16O3] 196.1099, HPLC 
analysis: Chiralcel AS-H (Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 23°C), 21.2 (major), 
24.1 min, 20% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 3,3-dimethylbutanoate (106s) white solid 80% 
yield, 
1
H NMR (500 MHz, CDCl3) δ 2.66 (ddd, J = 15.9, 3.3, 1.7 Hz, 1H), 2.59 – 2.43 (m, 
1H), 2.38 (d, J = 5.5 Hz, 2H), 2.36 – 2.22 (m, 2H), 2.04 – 1.91 (m, 1H), 1.11 (s, 9H), 0.94 
(s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.63, 170.14, 145.16, 135.96, 47.22, 45.12, 




266.1882, HPLC analysis: Chiralcel OJ-H (Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 23°C), 
8.9 (major), 9.7 min, 23% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl cinnamate (106t) white solid 80% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 7.82 (d, J = 16.0 Hz, 1H), 7.57 (dd, J = 6.7, 2.8 Hz, 2H), 7.42 
(dd, J = 4.9, 1.7 Hz, 3H), 6.58 (d, J = 16.0 Hz, 1H), 2.71 (ddd, J = 15.9, 3.3, 1.6 Hz, 1H), 
2.56 (dddd, J = 18.4, 6.3, 4.5, 1.7 Hz, 1H), 2.38 (ddd, J = 30.5, 17.8, 9.1 Hz, 2H), 2.10 – 
1.98 (m, 1H), 0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.80, 164.72, 146.90, 145.13, 
136.18, 134.19, 130.66, 128.94, 128.33, 116.55, 45.16, 39.95, 32.37, 27.04, 26.54. HRMS 
(EI) m/z 298.1572, calc. for [C19H22O3] 298.1569, HPLC analysis: Chiralcel OJ-H 
(Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 23°C), 36.1 (major), 38.4 min, 68% ee. 
 
(E)-4-(tert-butyl)-6-oxocyclohex-1-en-1-yl 2-methylbut-2-enoate (106u) white solid 89% 
yield, 
1
H NMR (500 MHz, CDCl3) δ 7.05 (q, J = 7.0 Hz, 1H), 6.62 (d, J = 6.4 Hz, 1H), 
2.68 (d, J = 15.7 Hz, 1H), 2.52 (dd, J = 18.1, 4.6 Hz, 1H), 2.33 (dd, J = 30.2, 15.2 Hz, 
2H), 2.01 (dd, J = 14.6, 11.0 Hz, 1H), 1.90 (s, 3H), 1.86 (d, J = 7.0 Hz, 3H), 0.95 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 192.95, 165.96, 145.43, 139.79, 135.82, 127.48, 45.20, 




250.1569, HPLC analysis: Chiralcel OD-H (Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 
23°C), 12.3 (major), 13.5 min, 70% ee. 
 
4-(tert-butyl)-6-oxocyclohex-1-en-1-yl pent-4-enoate (106v) white solid 90% yield, 
1
H 
NMR (500 MHz, CDCl3) δ 6.60 (dd, J = 6.6, 2.4 Hz, 1H), 5.88 (ddt, J = 16.8, 10.2, 6.4 
Hz, 1H), 5.08 (dddd, J = 29.3, 10.2, 3.0, 1.5 Hz, 2H), 2.71 – 2.58 (m, 3H), 2.57 – 2.41 (m, 
3H), 2.38 – 2.24 (m, 2H), 2.05 – 1.93 (m, 1H), 0.94 (s, 9H). 
13
C NMR (126 MHz, CDCl3) 
δ 192.65, 171.02, 145.12, 136.38, 135.99, 115.72, 45.14, 39.86, 32.93, 32.32, 28.71, 
27.01, 26.45. HRMS (EI) m/z 250.11579, calc. for [C15H22O3] 250.1569, HPLC analysis: 
Chiralcel OD-H (Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 23°C), 11.0 (major), 12.1 min, 
15% ee. 
 
1-methyl-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-4-yl benzoate white solid 62% yield,
 
1
H NMR (500 MHz, CDCl3) δ 8.10 (dd, J = 8.3, 1.2 Hz, 2H), 7.65 – 7.55 (m, 1H), 7.46 
(dd, J = 10.8, 4.8 Hz, 2H), 7.37 (d, J = 4.4 Hz, 4H), 7.36 – 7.14 (m, 1H), 6.65 (t, J = 4.4 
Hz, 1H), 3.16 – 3.02 (m, 2H), 2.91 – 2.79 (m, 2H), 1.52 (s, 3H). 
13
C NMR (126 MHz, 
CDCl3) δ 191.05, 164.66, 146.36, 145.61, 133.63, 130.29, 128.82, 128.69, 128.49, 126.69, 




306.1256, HPLC analysis: Chiralcel AD-H (Hex/IPA = 95/05, 0.5 mL/min, 230 nm, 
23°C), 16.5, 20.6 min, (major) 89% ee. 
 
3-bromo-5-(tert-butyl)-2-oxocyclohexyl 2,4,6-trimethylbenzoate white solid 55% 
1
H 
NMR (500 MHz, CDCl3) δ 6.87 (s, 2H), 5.48 (dd, J = 12.2, 6.8 Hz, 1H), 4.75 (dd, J = 
12.1, 6.1 Hz, 1H), 2.73 – 2.65 (m, 1H), 2.40 (s, 6H), 2.28 (s, 3H), 1.98 – 1.69 (m, 4H), 
0.97 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 195.75, 139.77, 135.85, 128.55, 75.04, 53.28, 





pale white solid 10% 
yield, 
1
H NMR (500 MHz, CDCl3) δ 8.00 (ddd, J = 7.7, 3.6, 1.3 Hz, 4H), 7.41 (td, J = 7.7, 
1.1 Hz, 2H), 7.17 (td, J = 7.7, 1.7 Hz, 2H), 5.64 (dd, J = 12.5, 6.4 Hz, 2H), 2.62 – 2.48 (m, 
2H), 1.90 (dd, J = 9.0, 6.2 Hz, 1H), 1.79 (q, J = 12.4 Hz, 2H), 1.01 (s, 9H). 
13
C NMR (126 
MHz, CDCl3) δ 198.20, 164.98, 141.37, 134.09, 133.02, 131.64, 127.96, 94.38, 75.56, 
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 LRMS (ESI) m/z 189.1 (M + H
+
), HRMS (ESI) m/z 189.1274 (M + H
+



































































Identification code tch26 
Chemical formula C12H12Br2O 
Formula weight 332.04 g/mol 
Temperature 103(2) K 
Wavelength 0.71073 Å 
Crystal size 0.220 x 0.380 x 0.420 mm 
Crystal habit colorless block 
Crystal system monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions a = 9.1707(8) Å α = 90° 
 
b = 15.3572(15) Å β = 111.578(3)° 
 






Density (calculated) 1.869 g/cm
3
 









Identification code tch27 
Chemical formula C10H16Br2O 
Formula weight 312.05 g/mol 
Temperature 103(2) K 
Wavelength 0.71073 Å 
Crystal size 0.120 x 0.280 x 0.400 mm 
Crystal habit colorless block 
Crystal system orthorhombic 
Space group P n m a 
Unit cell dimensions a = 6.3091(16) Å α = 90° 
 
b = 12.927(3) Å β = 90° 
 






Density (calculated) 1.769 g/cm
3
 









Identification code tch22 
Chemical formula C14H14O3 
Formula weight 230.25 
Temperature 103(2) K 
Wavelength 0.71073 Å 
Crystal size 0.280 x 0.340 x 0.400 mm 
Crystal habit colorless block 
Crystal system monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions a = 8.9009(10) Å α = 90° 
 
b = 9.6930(10) Å β = 98.901(4)° 
 






Density (calculated) 1.336 g/cm
3
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